ليست عنوان مقالات لاتين Prognosis of Traumatic Injuries to the Anterior Teeth (Treated in Shahid Beheshti and Tehran Dental Schools During 1996-2001) Prognostic value of strain and strain rate in the prediction of postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting: a systematic literature review

<< مقالات لاتين >>

<< بر اساس عنوان >>

1

Prognosis of Traumatic Injuries to the Anterior Teeth (Treated in Shahid Beheshti and Tehran Dental Schools During 1996-2001)

2

Prognosis prediction in traumatic brain injury patients using machine learning algorithms

3

Prognosis, Survival and Management of Pediatric Patients With Neuroblastoma: A 12-Year Experience From a Single Center Study

4

Prognosis, treatment, and recurrence of breast cancer for women attending or not attending the Screening Mammography Program of British Columbia

5

Prognosis, treatment, and recurrence of breast cancer for women attending or not attending the Screening Mammography Program of British Columbia

6

Prognostic Accuracy of B-Natriuretic Peptide Measurements and Coronary Artery Calcium in Asymptomatic Subjects (from the Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research [EISNER] Study)

7

Prognostic Accuracy of Cardiovascular Disease Biomarkers in Patients with COVID-19: A Diagnostic Test Accuracy Meta‐analysis

8

prognostic accuracy of the quick sequential organ failure assessment score and national early warning scores in mortality rate of the non-traumatic patients

9

Prognostic Accuracy of the Quick Sequential Organ Failure Assessment Score and National Early Warning Scores in mortality rate of the Non-Traumatic Patients

10

Prognostic and Clinical Value of CD44 and CD133 in Esophageal Cancer: A Systematic Review and Meta-analysis

11

Prognostic and Clinicopathological Implications of NUSAP1, MELK and L1CAM Immunohistochemical Expression in Cervical Cancer

12

Prognostic and Demographic Characteristics of Acute Myelogenous Leukemia Patients: a FiveYear Study in Mashhad, Iran

13

Prognostic and diagnostic relevance of hnRNP A2/B1, hnRNP B1 and S100 A2 in non-small cell lung cancer

14

Prognostic and predictive biomarkers of canine osteosarcoma

15

Prognostic and predictive factors after surgical treatment for locally recurrent rectal cancer: A single institute experience

16

Prognostic and predictive factors in breast cancer

17

Prognostic and predictive factors in primary breast cancer and their role in patient management: The Nottingham Breast Team

18

Prognostic and predictive factors in prostate cancer

19

Prognostic and predictive factors revisited

20

Prognostic and predictive value of 16p12.1 and 16q22.1 copy number changes in human breast cancer

21

Prognostic and predictive value of the thymidylate synthase expression in patients with non-metastatic colorectal cancer

22

Prognostic and Remaining Life Prediction of Electronic Device under Vibration Condition Based on CPSD of MPI

23

Prognostic application of arterial stiffness: task forces

24

Prognostic Assessment of Coronary Artery Bypass Patients With 64-Slice Computed Tomography Angiography: Anatomical Information Is Incremental to Clinical Risk Prediction

25

Prognostic Associations of Minnesota Code Serial Electrocardiographic Change Classification With Coronary Heart Disease Mortality in the Multiple Risk Factor Intervention Trial

26

Prognostic Biomarkers in ST-Segment Elevation Myocardial Infarction: A Step Toward Personalized Medicine or a Tool in Search of an Application?

27

Prognostic classification of breast ductal carcinoma-in-situ

28

Prognostic Comparison between Mucinous and Non-mucinous Rectal Adenocarcinoma

29

prognostic computer model to predict individual outcome in interventional cardiology—The INTERVENT project

30

Prognostic contribution of the HER-2 oncogene overexpression to the Nottingham Prognostic Index in breast cancer

31

Prognostic Correlation of an Autophagy-Related Gene Signature in Patients with Head and Neck Squamous Cell Carcinoma

32

Prognostic Cut Point for Breast Cancer Age of Diagnosis

33

Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone

34

Prognostic differences between atrial fibrillation and atrial flutter

35

Prognostic Effect of Coronary Flow Reserve in Women Versus Men With Chest Pain Syndrome and Normal Dipyridamole Stress Echocardiography

36

Prognostic Effect of Long-Axis Left Ventricular Dysfunction and B-Type Natriuretic Peptide Levels in Asymptomatic Aortic Stenosis

37

Prognostic effect of renal dysfunction after ST-segment elevation myocardial infarction with and without heart failure

38

Prognostic effect of serum and tissue YKL-40 levels in bladder cancer

39

Prognostic Effects of Selective Serotonin Reuptake Inhibitors in Patients With Coronary Artery Bypass Grafting

40

Prognostic Evaluation by Clinical Exercise Test Scores in Patients Treated With Primary Percutaneous Coronary Intervention or Fibrinolysis for Acute Myocardial Infarction (a Danish Trial in Acute Myocardial Infarction-2 Sub-Study)

41

Prognostic Evaluation of Ambulatory Patients With Advanced Heart Failure

42

Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunction

43

Prognostic evaluation of patients with parenchymal cirrhosis : Proposal of a new simple score

44

Prognostic evaluation of preoperative combined treatment for advanced cancer in the lower rectum with radiation, intraluminal hyperthermia, and 5-fluorouracil suppository

45

Prognostic factors affecting disease-free survival after hepatic resection for hepatocellular carcinoma in cirrhotic liver

46

Prognostic Factors Affecting Short- and Long-Term Recurrence-Free Survival of Patients with Rectal Cancer using Cure Models: A Cohort Study

47

Prognostic Factors Affecting the Mortality of Neonates with Duodenal Obstruction at RSUD Dr. Soetomo

48

Prognostic Factors Affecting the Results of Modified Thompson Quadricepsplasty for the Treatment of Extension Contracture of the Knee

49

Prognostic factors after resection of hepatocellular carcinoma: are there landmarks in the wild forest?

50

Prognostic factors after surgery for locally recurrent rectal cancer: An overview

51

Prognostic factors after surgery of primary resectable gastrointestinal stromal tumours

52

Prognostic factors after surgical treatment of lung cancer invading the diaphragm

53

Prognostic Factors and Analysis of Microsatellite Instability in Resected Pulmonary Metastases From Colorectal Carcinoma

54

Prognostic factors and clinicopathologic characteristics of invasive adenocarcinoma of the uterine cervix

55

Prognostic factors and early predictability of sustained viral response with peginterferon alfa-2a (40KD)

56

Prognostic factors and long-term effects of ursodeoxycholic acid on liver biochemical parameters in patients with primary biliary cirrhosis

57

PROGNOSTIC FACTORS AND MORTALITY RATE IN NEONATES WITH ACUTE RENAL INJURY IN NICU

58

Prognostic factors and new therapeutic approaches to cervical cancer

59

Prognostic factors and outcome in women with uterine sarcoma

60

Prognostic factors and preoperative radiation therapy associated with sphincter preservation in patients with resectable rectal cancer

61

Prognostic factors and relative risk for survival in N1–3 oral squamous cell carcinoma: a multivariate analysis using Cox’s hazard model

62

Prognostic factors and results after surgical treatment of primary sarcomas of the lung

63

Prognostic Factors and Surgical Indications of Pulmonary Epithelioid Hemangioendothelioma: A Review of the Literature

64

Prognostic Factors and Survival of Glioblastoma Multiform (GBM) in Iranian Patients

65

Prognostic Factors and Survival of Glioblastoma Multiform (GBM) in Iranian Patients

66

Prognostic factors associated with antenatal subchorionic echolucencies

67

Prognostic factors associated with pressure sore development in the immediate post-operative period

68

Prognostic Factors Associated with Survival in Patients Infected with COVID-19: A Retrospective Study on 214 Patients from Iran

69

Prognostic factors associated with the clinical outcome of cervical intraepithelial neoplasia: a cohort study in Japan

70

Prognostic factors for atherosclerosis progression in saphenous vein grafts : The postcoronary artery bypass graft (post-CABG) trial

71

Prognostic factors for chronic neck pain in persons with Minor or moderate injuries in traffic accidents

72

Prognostic factors for cryotherapy of colorectal liver metastases

73

Prognostic factors for first recurrence in patients with retroperitoneal sarcoma

74

Prognostic Factors for Fournier’s Gangrene; A 10-year Experience in Southeastern Iran

75

Prognostic factors for gastric cancer in the elderly

76

Prognostic factors for health-related quality of life in adults and children with primary antibody deficiencies receiving SCIG home therapy

77

Prognostic Factors for Improvement of Attention Deficit Hyperactivity Disorder (ADHD)

78

Prognostic factors for myasthenia gravis treated by thymectomy: review of 61 cases

79

Prognostic Factors for Pediatric Acute Liver Failure: A Systematic Review and Meta-analysis of Prognostic Studies

80

Prognostic Factors for Predicting COVID-19 Severity and Mortality

81

Prognostic factors for renal cell carcinoma

82

Prognostic factors for skeletal relapse in breast cancer

83

Prognostic factors for stereopsis in refractive accommodative esotropia

84

Prognostic factors for success of endometrial ablation and resection

85

Prognostic factors for success of endometrial ablation and resection

86

Prognostic factors for survival after isolated limb perfusion for malignant melanoma

87

Prognostic factors for survival after pulmonary resection of metastatic renal cell carcinoma

88

PROGNOSTIC FACTORS FOR SURVIVAL AT 6-MONTH FOLLOW-UP OF HOSPITALIZED PATIENTS WITH DECOMPENSATED CONGESTIVE HEART FAILURE

89

Prognostic factors for survival in pancreatic cancer: a population-based study

90

Prognostic Factors for Survival in Patients with Colorectal Cancer in Iran between 2004-2015: Competing Risks Regression Analysis with Generalized Weibull Model

91

Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma. Motzer RJ, Bacik J, Schwartz LH, Reuter V, Russo P, Marion S, Mazumdar M, Genitourinary Oncology Service, Division of Solid Tumor Oncology, Department of

92

Prognostic Factors for Survival of Patients with Glioblastoma in the Southern Region of Morocco

93

Prognostic factors for the development of gangrenous cholecystitis

94

Prognostic factors for the survival of patients with esophageal cancer in Northern Iran

95

Prognostic factors for tobacco consumption reduction after relapse

96

Prognostic factors for unstable proximal humeral fractures treated with locking-plate fixation

97

Prognostic factors impacting clinical outcome following Malassezia folliculitis treatment

98

Prognostic factors in acute cardiogenic pulmonary edema

99

Prognostic factors in acute cardiogenic pulmonary edema

100

Prognostic factors in acute myeloid leukaemia

101

Prognostic factors in adenocarcinoma of the cardia

102

Prognostic factors in adult granulosa cell tumor of the ovary

103

Prognostic factors in allogeneic transplantation for patients with high-risk multiple myeloma after reduced intensity conditioning

104

Prognostic factors in birth time: A Survival Analysis

105

Prognostic factors in clinical stage I non–small cell lung cancer

106

Prognostic factors in controlied ovarian hyperstimulation

107

Prognostic Factors in Crescentic Glomerulonephritis A Single-Center Experience

108

Prognostic factors in follicular carcinoma of the thyroid—a multivariate survival analysis

109

Prognostic factors in hanging injuries

110

Prognostic factors in hereditary and sporadic breast cancers: analysis of an Italian series of 602 patients

111

Prognostic factors in intramedullary astrocytomas

112

Prognostic factors in major depression: A long-term follow-up study of 323 patients

113

Prognostic factors in maxillary sinus and nasal cavity carcinoma

114

Prognostic factors in metastatic prostate cancer

115

Prognostic Factors in Multiple Myeloma: National Cancer Institute Experience

116

Prognostic factors in multiple myeloma: selection using Coxʹs proportional hazard model

117

Prognostic factors in neuroendocrine lung tumors: a Spanish multicenter study

118

Prognostic factors in node-negative intrahepatic cholangiocarcinoma with special reference to angiogenesis

119

Prognostic factors in non-small cell lung cancer surgery

120

Prognostic factors in patients continuing in vitro fertilization or intracytoplasmic sperm injection treatment and dropouts

121

Prognostic factors in patients with acute ischemic stroke treated with intravenous tissue plasminogen activator: The first study among Iranian patients

122

Prognostic factors in patients with acute ischemic stroke treated with intravenous tissue plasminogen activator: The first study among Iranian patients

123

PROGNOSTIC FACTORS IN PATIENTS WITH APPENDICULAR MYXOFIBROSARCOMA

124

Prognostic factors in patients with glioblastoma multiforme (clinical research)

125

Prognostic Factors in Patients With Implantable Cardioverter-Defibrillators

126

Prognostic factors in patients with isolated recurrences of breast cancer (stage IV-NED)

127

Prognostic factors in patients with isolated recurrences of breast cancer (stage IV-NED)

128

Prognostic factors in patients with malignant fibrous histiocytoma of the extremities

129

Prognostic factors in patients with surgically resected stages I and II non-small cell lung cancer

130

Prognostic Factors in Resected Satellite–Nodule T4 Non-Small Cell Lung Cancer

131

Prognostic factors in soft tissue leiomyosarcoma of the extremities: a retrospective analysis of 42 cases

132

Prognostic factors in soft tissue sarcomas: a study of 395 patients

133

Prognostic Factors in the Management of Exacerbation of Chronic Obstructive Pulmonary Disease in Kuwait

134

Prognostic factors in the palliation of pancreatic cancer

135

Prognostic Factors in the Relapse of Graves’ Disease Following Treatment with Antithyroid Drugs

136

Prognostic Factors in Thymic Epithelial Tumors Undergoing Complete Resection

137

PROGNOSTIC FACTORS IN TYPHOID ILEAL PERFORATION: A PROSPECTIVE STUDY OF 98 PATIENTS AT SAIDU GROUP OF TEACHING HOSPITALS, SWAT

138

Prognostic factors in metastatic nasopharyngeal carcinoma

139

Prognostic factors of 28 days survival rate in patients with a first acute myocardial

140

Prognostic Factors of Acute Lymphoblastic Leukeamia in Children

141

Prognostic Factors of Anaplastic Thyroid Carcinoma: An Egyptian Single Institution Experience

142

Prognostic factors of Atractylis gummifera L. poisoning, Morocco

143

Prognostic Factors of Concomitant Hyperglycemia and Hypocalcemia in Pediatric Intensive Care Units

144

Prognostic Factors of Depression in Patients With Cancer Undergoing Chemotherapy and Radiotherapy

145

Prognostic factors of extremity soft tissue sarcoma in adults. A single institutional analysis

146

Prognostic factors of first birth interval using the parametric survival models

147

Prognostic Factors of Functional Recovery from Left Hemispheric Stroke

148

Prognostic factors of gastric cancer tumours of less than 2 cm in diameter: rationale for limited surgery

149

prognostic factors of in-hospital mortality in adult patients with aluminum phosphide (alp) poisoning in southern iran (2014-2018)

150

Prognostic Factors of Initial Chest CT Findings for ICU Admission and Mortality in Patients with COVID-19 Pneumonia

151

Prognostic factors of neuroinflammation and oxidative stress in brain injury patients at Cipto Mangunkusumo Hospital Jakarta

152

Prognostic factors of oncologic outcomes after fertility‑preservative management with progestin in early‑stage of endometrial cancer

153

Prognostic Factors of Outcome in Methanol Poisoning; an 8-year Retrospective Cross-sectional Study

154

Prognostic factors of patients with mycosis fungoides

155

Prognostic factors of patients with yolk sac tumors of the ovary

156

Prognostic factors of postoperative intraretinal cystoid spaces after primary pars plana vitrectomy for vitreomacular traction

157

Prognostic Factors of Pregnancy in 500 Cases of Intrauterine Insemination in Babol, Northern Iran

158

Prognostic Factors of Pregnancy in 500 Cases of Intrauterine Insemination in Babol, Northern Iran

159

Prognostic Factors of Radiofrequency Ablation plus Systemic Chemotherapy for Unresectable Colorectal Cancer with Liver Metastasis

160

Prognostic factors of recurrence and neck metastasis in oral carcinomas

161

Prognostic Factors of Renal Dysfunction Induced by Environmental Cadmium Pollution

162

Prognostic Factors of Severe Traumatic Brain Injury Outcome in Children Aged 2-16 Years at A Major Neurosurgical Referral Centre

163

Prognostic Factors of Surgery for Cervical Cord Tumors

164

Prognostic Factors of Survival Rate in Oral Squamous Cell Carcinoma: Clinical, Histologic, Genetic and Molecular Concepts

165

Prognostic factors of thymomas

166

Prognostic factors predicting survival from first recurrence in patients with metastatic breast cancer: analysis of 439 patients

167

Prognostic factors predicting survival from first recurrence in patients with metastatic breast cancer: analysis of 439 patients

168

Prognostic factors predicting survival in the treatment of retroperitoneal sarcoma

169

Prognostic features of multiple myeloma

170

Prognostic histopathological and molecular markers in feline mammary neoplasia

171

Prognostic Impact of Acute Beta-Blocker Therapy on Top of Aspirin and Angiotensin-Converting Enzyme Inhibitor Therapy in Consecutive Patients With ST-Elevation Acute Myocardial Infarction

172

Prognostic Impact of Adjuvant Radiotherapy in Breast Cancer Patients with One to Three Positive Axillary Lymph Nodes

173

Prognostic impact of ambulatory blood pressure control in treated hypertensive patients

174

Prognostic Impact of Angiotensin-Converting Enzyme Inhibitor Therapy in Diastolic Heart Failure

175

Prognostic impact of autonomic information flow in multiple organ dysfunction syndrome patients

176

Prognostic impact of big endothelin-1 plasm concentrations compared with invasive hemodynamic evaluation in severe heart failure

177

Prognostic impact of body weight and abdominal obesity in women and men with cardiovascular disease

178

Prognostic impact of chromosome alterations detected by FISH in Turkish patients with B-cell chronic lymphocytic leukemia

179

Prognostic Impact of Circulating CD28 Negative Suppressor T Cells and Memory B Cells on Treatment Outcomes of Patients with Breast Cancer

180

Prognostic Impact of Cirrhosis in Patients with Intrahepatic Cholangiocarcinoma following Hepatic Resection

181

Prognostic Impact of Cytoreductive Nephrectomy in Patients with Metastatic Renal Cell Carcinoma: Data from a Large Population-Based Database

182

Prognostic impact of definitive local therapy of the primary tumor in men with metastatic prostate cancer at diagnosis: A population-based, propensity score analysis

183

Prognostic impact of Deoxyribonucleic acid (DNA) image analysis cytometry and immunohistochemical expression of Ki67 in surgically resected non-small cell lung cancers

184

Prognostic Impact of Diabetes Mellitus in Patients With Acute Decompensated Heart Failure

185

Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction

186

Prognostic impact of DNA content and AUER classification in primary fallopian tube carcinoma

187

Prognostic Impact of Interleukin-10 in Patients with Chronic Lymphocytic Leukemia

188

Prognostic impact of left bundle-branch block in the early stable phase after acute myocardial infarction

189

Prognostic impact of matrix metalloproteinases (MMP-9 and MMP-2) and vascular endothelial growth factor expression in non-small cell lung cancer

190

Prognostic Impact of Monocyte to Lymphocyte Ratio in Clinical Outcome for Patients with Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis

191

Prognostic impact of neuropilin-1 expression in children with B-lineage acute lymphoblastic leukemia: Retraction

192

Prognostic impact of p53 protein overexpression in patients with node-negative lung adenocarcinoma

193

Prognostic impact of peakVO2-changes in stable CHF on chronic beta-blocker treatment

194

Prognostic impact of pre-operative albumin on short-term mortality and complications in patients with hip fracture

195

Prognostic impact of pulmonary arterial hypertension: A population-based analysis

196

Prognostic Impact of Pulmonary Artery Systolic Pressure in Patients Undergoing Transcatheter Aortic Valve Replacement for Aortic Stenosis

197

Prognostic Impact of Q Waves on Presentation and ST Resolution in Patients With ST-Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention

198

Prognostic impact of renal dysfunction on long-term mortality in patients with preserved, moderately impaired, and severely impaired left ventricular systolic function following myocardial infarction

199

Prognostic impact of right ventricular involvement as assessed by tricuspid annular motion in patients with acute myocardial infarction

200

Prognostic Impact of Staged Versus “One-Time” Multivessel Percutaneous Intervention in Acute Myocardial Infarction: Analysis From the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) Trial

201

Prognostic impact of SUMO-specific protease 1 (SENP1) in prostate cancer patients undergoing radical prostatectomy

202

Prognostic impact of SUMO-specific protease 1 (SENP1) in prostate cancer patients undergoing radical prostatectomy

203

Prognostic Impact of Systolic Hypertension on Asymptomatic Patients With Chronic Severe Aortic Regurgitation and Initially Normal Left Ventricular Performance at Rest

204

Prognostic Impact of TEL–AML-1 Fusion Gene on Acute Lymphoblastic Leukemia

205

Prognostic Impact of the Presence and Absence of Angina on Mortality and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Stable Coronary Artery Disease: Results from the BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes)

206

Prognostic Impact of Thrombolysis in Myocardial Infarction Risk Index on Hospitalization Mortality of Patient with Acute Pulmonary Embolism

207

Prognostic impact of tumor size on pT2 renal cell carcinoma: An international multicenter experience: Klatte T, Patard JJ, Goel RH, Kleid MD, Guille F, Lobel B, Abbou CC, De La Taille A, Tostain J, Cindolo L, Altieri V, Ficarra V, Artibani W, Prayer-Galet

208

Prognostic impact of tumour cell detection in patients with early (T1) and locally advanced breast cancer

209

Prognostic Impact of Types of Atrial Fibrillation in Acute Coronary Syndromes

210

Prognostic impact of workload in patients with congestive heart failure

211

Prognostic Implication and Survival Outcomes of Perioperative Blood Transfusion on Urological Malignancies Undergoing Radical Surgical Intervention

212

Prognostic Implication of Adrenocortical Response during the Course of Critical Illness

213

Prognostic implication of creatine kinase release after elective percutaneous coronary intervention in the pre-IIb/IIIa antagonist era

214

Prognostic implication of early ejection fraction on long-term mortality and quality of life following out-of-hospital cardiac arrest

215

Prognostic Implication of Hyperglycemia in Myocardial Infarction and Primary Angioplasty

216

Prognostic implication of Ki-67 immunostaining in treating subclinical pleural cancer found at thoracotomy in lung cancer patients

217

Prognostic implication of pretreatment plasma/serum concentration of Epstein-Barr virus DNA in nasopharyngeal carcinoma

218

Prognostic implication of redefining indeterminate microvolt T-wave alternans studies as abnormal or normal

219

Prognostic implication of troponin I elevation after percutaneous coronary intervention

220

Prognostic implication of valvular lesion and left ventricular size in asymptomatic patients with chronic organic mitral regurgitation and normal left ventricular performance

221

Prognostic implications derived from ultrasonic tissue characterization with myocardial integrated backscatter in patients with dilated cardiomyopathy

222

Prognostic implications for gastric carcinoma based on loss of heterozygosity genotypes correlation with clinicopathologic variables

223

Prognostic Implications of a Normal Stress Technetium-99m–Tetrofosmin Myocardial Perfusion Study in Patients With a Healed Myocardial Infarct and/or Previous Coronary Revascularization

224

Prognostic implications of ambulatory myocardial ischemia and arrhythmias and relations to ischemia on exercise in chronic stable angina pectoris (the Angina Prognosis Study In Stockholm [APSIS])

225

Prognostic implications of atrial fibrillation in patients undergoing myocardial perfusion single-photon emission computed tomography Original Research Article

226

Prognostic implications of autonomic nervous system analysis in chronic heart failure: Role of heart rate variability and baroreflex sensitivity

227

Prognostic Implications of Baroreflex Sensitivity in Heart Failure Patients in the Beta-Blocking Era

228

Prognostic Implications of Bundle Branch Block in Patients Undergoing Primary Coronary Angioplasty in the Stent Era

229

Prognostic Implications of Coronary Flow Reserve on Left Anterior Descending Coronary Artery in Hypertrophic Cardiomyopathy

230

Prognostic Implications of Creatine Kinase Elevation After Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction Original Research Article

231

Prognostic implications of detection of troponin I in patients with unstable angina pectoris

232

Prognostic Implications of Dipyridamole or Dobutamine Stress Echocardiography for Evaluation of Patients ≥65 Years of Age With Known or Suspected Coronary Heart Disease

233

Prognostic implications of ejection fraction from linear echocardiographic dimensions: the strong heart study

234

Prognostic implications of elevated troponin in patients with suspected acute coronary syndrome but no critical epicardial coronary disease: A TACTICS-TIMI-18 substudy Original Research Article

235

Prognostic implications of elevated whole blood choline levels in acute coronary syndromes

236

Prognostic implications of evaluation of contractile reserve in akinetic and hypokinetic segments during low dose dobutamine echocardiography in patients with acute myocardial infarction

237

Prognostic Implications of Exercise Echocardiography in Women With Known or Suspected Coronary Artery Disease

238

Prognostic implications of fetal echogenic bowel

239

Prognostic implications of hyponatremia in elderly hospitalized patients

240

Prognostic implications of I-123 metaiodobenzylguanidine (MIBG) in patients with idiopathic dilated cardiomyopathy (DCM) and receiving β-blockade treatment

241

Prognostic implications of increased QRS duration in patients with moderate and severe left ventricular systolic dysfunction

242

Prognostic implications of inhalation injury in burn patients in Tokyo

243

Prognostic implications of intraventricular conduction defects in patients undergoing stress echocardiography for suspected coronary artery disease

244

Prognostic Implications of Left Atrial Volume Index in Patients in Sinus Rhythm

245

Prognostic implications of left ventricular hypertrophy

246

Prognostic Implications of Mental Stress-Induced Silent Loft Ventricular Dysfunction in Patients With Stable Angina Pectoris

247

Prognostic implications of microscopic proximal bronchial extension in non-small cell lung cancer

248

Prognostic implications of monosomy 3 in uveal melanoma

249

Prognostic implications of myocardial contractile reserve in patients with coronary artery disease and left ventricular dysfunction

250

Prognostic implications of myocardial necrosis triad markersʹ concentration measured at admission in patients with suspected acute coronary syndrome

251

Prognostic Implications of Nonobstructive Coronary Artery Disease in Patients Undergoing Coronary Computed Tomographic Angiography for Acute Chest Pain

252

Prognostic Implications of Nonobstructive Coronary Plaques in Patients With Non–ST-Segment Elevation Myocardial Infarction: A Multidetector Computed Tomography Study

253

Prognostic Implications of Normal (<0.10 ng/ml) and Borderline (0.10 to 1.49 ng/ml) Troponin Elevation Levels in Critically Ill Patients Without Acute Coronary Syndrome

254

Prognostic Implications of Preoperative Atrial Fibrillation in Patients Undergoing Aortic Valve Replacement: Is There an Argument for Concomitant Arrhythmia Surgery?

255

Prognostic Implications of Prominent R Wave in Electrocardiographic Leads V1 or V2 in Patients With Acute Coronary Syndrome

256

Prognostic Implications of Restrictive Left Ventricular Filling in Acute Myocardial Infarction: Serial Doppler Echocardiographic Study

257

Prognostic implications of restrictive left ventricular filling in reperfused anterior acute myocardial infarction

258

Prognostic Implications of ST-Segment Elevation Resolution in Patients With ST-Segment Elevation Acute Myocardial Infarction Treated With Primary or Facilitated Percutaneous Coronary Intervention

259

Prognostic implications of Tc-99m sestamibi viability imaging and subsequent therapeutic strategy in patients with chronic coronary artery disease and left ventricular dysfunction

260

Prognostic Implications of the Doppler Restrictive Filling Pattern in Hypertrophic Cardiomyopathy

261

Prognostic Implications of the Doppler Restrictive Filling Pattern in Hypertrophic Cardiomyopathy

262

Prognostic Implications of the High-Sensitive C-Reactive Protein in the Catheter Ablation of Atrial Fibrillation

263

Prognostic implications of TIMI flow grade in the infarct related artery compared with continuous 12-lead ST-segment resolution analysis: Reexamining the “gold standard” for myocardial reperfusion assessment

264

Prognostic Importance of Atrial Fibrillation in Implantable Cardioverter-Defibrillator Patients

265

Prognostic importance of complete atrioventricular block complicating acute myocardial infarction

266

Prognostic importance of concomitant heparin with eptifibatide in acute coronary syndromes

267

Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma

268

Prognostic importance of elevated troponin T and creatine kinase after elective angioplasty

269

Prognostic importance of hyponatremia in acute ST-elevation myocardial infarction

270

Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies

271

Prognostic importance of insulin-mediated glucose uptake in aged patients with congestive heart failure secondary to mitral and/or aortic valve disease

272

Prognostic importance of isolated T-wave abnormalities

273

Prognostic importance of lower extremity arterial disease in patients undergoing coronary revascularization in the bypass angioplasty revascularization investigation (BARI)

274

Prognostic importance of lymphopenia in West Nile encephalitis

275

Prognostic importance of marital quality for survival of congestive heart failure

276

Prognostic importance of new small Q waves following Non–ST-Elevation acute coronary syndromes

277

Prognostic importance of presenting symptoms in patients undergoing exercise testing for evaluation of known or suspected coronary disease

278

Prognostic importance of renal function in patients with early heart failure and mild left ventricular dysfunction

279

Prognostic importance of right ventricular infarction in an acute myocardial infarction cohort referred for contemporary percutaneous reperfusion therapy

280

Prognostic Importance of Scintigraphic Left Ventricular Cavity Dilation During Intravenous Dipyridamole Technetium-99m Sestamibi Myocardial Tomographic Imaging in Predicting Coronary Events

281

Prognostic Importance of Secondary Pulmonary Hypertension After Acute Myocardial Infarction

282

Prognostic importance of serial cytokine changes in ascites and pleural effusion in women with severe ovarian hyperstimulation syndrome

283

Prognostic importance of systolic and diastolic function after acute myocardial infarction

284

Prognostic importance of the length of ventricular tachycardia in patients with nonischemic congestive heart failure

285

Prognostic importance of the oxidized product of catecholamines, adrenolutin, in patients with severe heart failure

286

Prognostic importance of the quantification of myocardial viability in revascularized patients with coronary artery disease and moderate-to-severe left ventricular dysfunction

287

Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia

288

Prognostic importance of troponin T and creatine kinase after elective angioplasty

289

Prognostic Importance of Wall Motion Abnormalities in Patients With Ischemic Cardiomyopathy and an Implantable Cardioverter-Defibrillator

290

Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study

291

Prognostic indexes in breast cancer: comparison of the Nottingham and Adelaide indexes

292

Prognostic indicators and burns

293

Prognostic indicators for conventional complete denture therapy: A review of the literature

294

Prognostic indicators for conventional complete denture therapy: A review of the literature

295

Prognostic indicators for long term outcome following radical retropubic prostatectomy for prostate cancer involving the seminal vesicles

296

Prognostic indicators of adverse renal outcome and death in acute kidney injury hospital survivors

297

Prognostic Indicators: Useful for Clinical Care?

298

Prognostic indices and screen-detected cancers: the size factor

299

Prognostic Influence of Diabetes Mellitus on Long-Term Clinical Outcomes and Stent Thrombosis After Drug-Eluting Stent Implantation in Asian Patients

300

Prognostic influence of multiple hepatic metastases from colorectal cancer

301

Prognostic influence of pregnancy before, around, and after diagnosis of breast cancer

302

Prognostic influence of the third Gleason grade in prostatectomy specimens

303

Prognostic information of gastric carcinoma using Goseki system in relation to nuclear organizer region (AgNOR) and proliferating cell nuclear antigen (PCNA) expression

304

Prognostic Information of Glycogen Phosphorylase Isoenzyme BB in Patients With Suspected Acute Coronary Syndrome

305

Prognostic information provided by serial measurements of brain natriuretic peptide in heart failure

306

Prognostic interaction between viability and residual myocardial ischemia by dobutamine stress echocardiography in patients with acute myocardial infarction and mildly impaired left ventricular function

307

Prognostic Interplay of Coronary Artery Calcification and Underlying Vascular Dysfunction in Patients With Suspected Coronary Artery Disease

308

Prognostic markers and new, innovative treatments in renal cell carcinoma

309

Prognostic markers for urothelial cancer: Obstacles and opportunities

310

Prognostic markers in chronic lympocytic leukaemia

311

Prognostic markers in renal cell carcinoma: A focus on the ‘mammalian target of rapamycin’ pathway

312

Prognostic Markers in Thrombolytic Therapy: Looking Beyond Mortality

313

Prognostic Meaning of Coronary Flow Reserve in Type 2 Diabetes Mellitus: A Transoesophageal Doppler Echo cardiographic Study

314

Prognostic methods in medicine

315

PROGNOSTIC MODELLING OF CRACK GROWTH IN A TENSIONED STEEL BAND

316

Prognostic models in chronic liver disease: validity, usefulness and future role

317

Prognostic models including the Child–Pugh, MELD and Mayo risk scores—where are we and where should we go?

318

Prognostic normative reasoning

319

Prognostic normative reasoning

320

Prognostic patch testing: The other kind of patch test

321

Prognostic patch testing: The other kind of patch test

322

Prognostic performance of ECG abnormalities compared to vital signs in acutely ill patients in a resource-poor hospital in Uganda

323

Prognostic Performance of High Expression of KIF23 and Loss of c-CBL in Gastric Cancer Patients: An Immunohistochemical Study

324

Prognostic Performance of Multiple Biomarkers in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome: Analysis From the MERLIN–TIMI 36 Trial (Metabolic Efficiency With Ranolazine for Less Ischemia in Non−ST-Elevation Acute Coronary Syndromes–Th

325

Prognostic personal credit risk model considering censored information

326

Prognostic potential of glutathione S-transferase M1 and T1 null genotypes for gastric cancer progression

327

Prognostic prediction in patients with metastatic renal cell carcinoma treated with sorafenib based on expression levels of potential molecular markers in radical nephrectomy specimens

328

Prognostic Prediction Value of qSOFA, SOFA, and Admission Lactate in Septic Patients with Community-Acquired Pneumonia in Emergency Department

329

Prognostic predictors of gastrointestinal stromal tumors: a multi-institutional analysis of 102 patients with definition of a prognostic index

330

Prognostic relevance of AgNORs in tumor pathology

331

Prognostic relevance of cyclooxygenase-2 (COX-2) expression in Chinese patients with prostate cancer

332

Prognostic relevance of Masaoka and Müller-Hermelink classification in patients with thymic tumors

333

Prognostic Relevance of Metabolic Syndrome in Hypertensive Patients at Low-to-Medium Risk

334

Prognostic relevance of mitotic activity in patients with node negative breast cancer

335

Prognostic Relevance of Monosomy at the 13q14 Locus Detected by Fluorescence In Situ Hybridization in B-Cell Chronic Lymphocytic Leukemia

336

Prognostic relevance of occult tumour cells in lymph nodes in colorectal cancer

337

Prognostic relevance of preoperative circulating CD8-positive lymphocytes in the urinary bladder recurrence of urothelial carcinoma

338

Prognostic relevance of receptor tyrosine kinase expression in breast cancer: A meta-analysis

339

Prognostic relevance of ultra-early doppler sonography in acute ischaemic stroke: a prospective multicentre study

340

Prognostic risk stratification derived from individual patient level data for men with advanced penile squamous cell carcinoma receiving first-line systemic therapy

341

Prognostic Role of Body Mass Index After Acute Myocardial Infarction

342

Prognostic role of B-type natriuretic peptide levels in patients with type 2 diabetes mellitus Original Research Article

343

Prognostic role of cardiovascular risk factors for men with cardiomegaly (the Reykjavik study)

344

Prognostic Role of CD44, Smoothelin and MUC1 in Urinary Bladder Carcinoma

345

Prognostic Role of CMR Imaging After Myocardial Infarction

346

Prognostic role of C-reactive protein in acute stroke

347

Prognostic role of cyclooxygenase-2 expression in esophageal carcinoma

348

Prognostic Role of Epithelial Mesenchymal Transition Transcription Factors in Carcinoma- A Systematic Review and Meta-Analysis

349

Prognostic role of fish detected her-2/neu amplification in early onset breast cancer

350

Prognostic Role of Flow-Mediated Dilation and Cardiac Risk Factors in Post-Menopausal Women Original Research Article

351

Prognostic Role of Gestational Age and Birth Weight in Nephrotic Syndrome: A Retrospective Cross-Sectional Study

352

Prognostic role of heart rate variability in patients with a recent acute myocardial infarction

353

Prognostic Role of Human Epidermal Growth Factor Receptor in Gastric Cancer: A Systematic Review and Meta-analysis

354

Prognostic role of immunosuppressive acidic protein in advanced ovarian cancer, , ,

355

Prognostic role of lymph-node level involvement in patients undergoing axillary dissection for breast cancer

356

Prognostic Role of Matrix Metalloproteinase-9 (MMP-9) in Patients with Osteosarcoma

357

Prognostic Role of Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio in the Survival of Patients with Esophageal Cancer

358

Prognostic role of oestrogen, progesterone and androgen receptor in relation to patient age in patients with breast cancer

359

Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women

360

Prognostic role of simplified Pulmonary Embolism Severity Index and the European Society of Cardiology Prognostic Model in short- and long-term risk stratification in pulmonary embolism

361

Prognostic role of soluble suppression of tumorigenicity-2 on cardiovascular mortality in outpatients with heart failure

362

Prognostic Role of Spiritual Intelligence Components in Pregnant Women’s Depression, Anxiety, and Stress

363

Prognostic role of subclinical left ventricular abnormalities and impact of transplantation in chronic kidney disease

364

Prognostic role of Tc-99m pertechnetate thyroid scintigraphy prior to fixed-dose radioiodine therapy of toxic multinodular goiters

365

Prognostic role of transesophageal echocardiography in acute type A aortic dissection

366

Prognostic Role of Troponin T Versus Troponin I in Unstable Angina Pectoris for Cardiac Events With Meta-Analysis Comparing Published Studies

367

Prognostic Serum Factors in Traumatic Brian Injury: A Systematic Review

368

Prognostic Significance and Determinants of Myocardial Salvage Assessed by Cardiovascular Magnetic Resonance in Acute Reperfused Myocardial Infarction

369

Prognostic significance and different properties of survivin splicing variants in gastric cancer

370

Prognostic Significance of a Clearly Audible Fourth Heart Sound Detected a Month After an Acute Myocardial Infarction

371

Prognostic Significance of a Histologic Subtype in Small Adenocarcinoma of the Lung: The Impact of Nonbronchioloalveolar Carcinoma Components

372

Prognostic Significance of Admission Heart Failure in Patients With Non–ST-Elevation Acute Coronary Syndromes (from the Canadian Acute Coronary Syndrome Registries)

373

Prognostic significance of an elevated creatine kinase in the absence of an elevated troponin I during an acute coronary syndrome

374

Prognostic significance of anemia in patients with chronic systolic heart failure secondary to Chagas’ cardiomyopathy

375

Prognostic Significance of Angina Pectoris ≥30 Days Before Acute Myocardial Infarction in Patients ≥75 Years of Age

376

Prognostic significance of apoptosis in laryngeal cancer. A quantitative immunomorphological study

377

Prognostic Significance of Atrial Fibrillation and Severity of Symptoms of Heart Failure in Patients With Low Gradient Aortic Stenosis and Preserved Left Ventricular Ejection Fraction

378

Prognostic significance of atrial fibrillation in patients at a tertiary medical center referred for heart transplantation because of severe heart failure

379

Prognostic significance of atrial fibrillation/atrial flutter in patients with acute myocardial infarction treated with percutaneous coronary intervention

380

Prognostic significance of Aurora-A expression in human bladder cancer

381

Prognostic significance of axillary node and infraclavicular lymph node status after mastectomy

382

Prognostic significance of B7-H3 expression in patients with colorectal cancer: A meta-analysis

383

Prognostic significance of bcl-2 expression in resected pN2 non-small cell lung cancer

384

PROGNOSTIC SIGNIFICANCE OF BCL-2, BAX AND P53 EXPRESSION IN BREAST CANCER

385

Prognostic significance of Bcl-2, p53 overexpression, and lymph node metastasis in surgically staged endometrial carcinoma

386

Prognostic significance of Bcl-xL gene expression in human colorectal cancer

387

Prognostic significance of blood pressure variability in essential hypertension.

388

Prognostic Significance of Body Mass Index and Other Tumor and Patient Characteristics in Non- Metastatic Renal Cell Carcinoma

389

Prognostic Significance of Bone-marrow Pattern and Immunophenotypic Score in B-chronic Lymphocytic Leukemia at Diagnosis

390

Prognostic significance of brain-derived neurotrophic factor levels in patients with heart failure and reduced left ventricular ejection fraction

391

Prognostic Significance of Carcinoembryonic Antigen Level in Pleural Lavage Fluid for Patients With Lung Adenocarcinoma

392

Prognostic Significance of Carcinoembryonic Antigen Level in Pleural Lavage Fluid for Patients With Lung Adenocarcinoma

393

Prognostic significance of carcinoembryonic antigen levels in peritoneal washes in patients with gastric cancer

394

Prognostic significance of caspase-3 expression in primary resected esophageal squamous cell carcinoma

395

Prognostic significance of CD44v5 expression in human thymic epithelial neoplasms

396

Prognostic significance of cerebrovascular and peripheral arterial disease in patients having percutaneous coronary interventions

397

Prognostic significance of cerebrovascular disease in 11,526 chronic coronary artery disease patients

398

Prognostic significance of CHADS2 and CHA2DS2-VASc scores to predict unfavorable outcomes in hospitalized patients with COVID-19

399

Prognostic significance of changes in the compliance of the pulmonary venous system after isosorbiddinitrate in patients with mitral stenosis

400

Prognostic significance of chronotropic response to dobutamine stress echocardiography in patients with peripheral arterial disease

401

Prognostic Significance of Circulating and Disseminated Tumor Cells in Breast Cancer Patients before and after Adjuvant Chemotherapy

402

Prognostic Significance of Circulating IL-10 and IL-6 Serum Levels in Colon Cancer Patients Undergoing Surgery

403

Prognostic significance of circulating levels of angiogenic cytokines in patients with congestive heart failure

404

Prognostic significance of circulating P53 antibodies in patients undergoing surgery for locoregional breast cancer

405

Prognostic significance of clinically silent coronary artery fistulas

406

Prognostic significance of clinicopathologic and deoxyribonucleic acid flow cytometric variables in non-metastatic renal cell carcinoma in the modern era

407

Prognostic significance of CLLU1 expression in B-cell chronic lymphocytic leukemia

408

Prognostic significance of coronary artery calcium in asymptomatic subjects with usual cardiovascular risk

409

Prognostic significance of coronary blood flow velocity patterns in patients with reperfused acute myocardial infarction and TIMI-2 flow

410

Prognostic significance of coronary blood flow velocity patterns in patients with reperfused acute myocardial infarction and TIMI-2 flow: Reply

411

Prognostic Significance of Coronary Calcific Deposits in Asymptomatic High-Risk Subjects

412

Prognostic Significance of Coronary Collaterals in Patients With Coronary Heart Disease Having Percutaneous Transluminal Coronary Angioplasty

413

Prognostic significance of COX-2 and β-catenin in colorectal carcinoma

414

Prognostic significance of creatine kinase-MB elevation after percutaneous coronary intervention in patients with chronic renal dysfunction

415

Prognostic significance of cytochrome C release and tissue lactate dehydrogenase in patients with breast cancer

416

Prognostic significance of cytogenetically detected chromosome 21 anomalies in childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study

417

Prognostic Significance of Cytokeratin Markers in Breast Cancer –a Meta Analysis

418

Prognostic significance of del 17p,ZAP-70 and CD38 as independent indicators for B-CLL: Correlation to response to treatment and disease outcome

419

Prognostic significance of del(20q) in patients with hematological malignancies

420

Prognostic significance of diabetes as a predictor of survival after cardiac catheterization

421

Prognostic significance of diabetes in acute myocardial infarction. Are the differences linked to female gender?

422

Prognostic significance of diabetes in acute myocardial infarction. Are the differences linked to female gender?

423

Prognostic significance of difficulties in mobility in a five-year follow-up study of four birth cohorts

424

Prognostic significance of DNA ploidy in squamous cell lung carcinoma: is it really worth it?

425

Prognostic significance of DNA ploidy in Ta/Tl bladder cancer: A southwest oncology group study

426

Prognostic significance of DNA ploidy pattern in osteosarcomas in association with chemotherapy

427

Prognostic significance of double product and inadequate double product response to maximal symptom-limited exercise stress testing after myocardial infarction in 6296 patients treated with thrombolytic agents

428

Prognostic significance of early short-term measurements of heart rate variability following acute myocardial infarction

429

Prognostic significance of echocardiographically defined mitral regurgitation early after acute myocardial infarction

430

Prognostic significance of echocardiographically estimated right ventricular shortening in advanced heart failure

431

Prognostic significance of EGF receptor expression in early glottic cancer

432

Prognostic Significance of Elevated Cardiac Troponin I After Heart Surgery

433

Prognostic significance of elevated hemostatic markers in patients with acute myocardial infarction

434

Prognostic significance of elevated troponin i after percutaneous coronary intervention

435

Prognostic Significance of Epicardial Blood Flow Before and After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes Original Research Article

436

Prognostic significance of ERRB3 overexpression in oral squamous cell carcinoma

437

Prognostic significance of erythropoietin expression in human renal cell carcinoma: Michael A, Politi E, Havranek E, Corbishley C, Karapanagiotou L, Anderson C, Relph K, Syrigos KN, Pandha H, Department of Oncology, St. George’s Hospital Medical School, L

438

Prognostic Significance of Exercise Induced Arrhythmias and Echocardiographic Variables in Hypertrophic Cardiomyopathy

439

Prognostic significance of exercise stress echocardiography in 3329 outpatients (5-year longitudinal study)

440

Prognostic significance of exercise-induced systemic hypertension in healthy subjects

441

Prognostic significance of fixed perfusion abnormalities on stress technetium-99m sestamibi single-photon emission computed tomography in patients without known coronary artery disease

442

Prognostic significance of flow cytometric quantification of circulating endothelial cells in chronic lymphocytic leukemia

443

Prognostic Significance of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography in Anal Squamous Cell Carcinoma: A Systematic Review and a Meta-Analysis

444

Prognostic Significance of Fragmented QRS Complex for Predicting the Risk of Recurrent Cardiac Events in Patients With Q-Wave Myocardial Infarction

445

Prognostic significance of glutamine synthetase expression in unifocal advanced hepatocellular carcinoma

446

PROGNOSTIC SIGNIFICANCE OF GLUTATHIONE S-TRANSFERASE µ3 mRNA EXPRESSION IN ACUTE LYMPHOBLASTIC LEUKEMIA

447

Prognostic significance of heart rate turbulence in patients undergoing coronary artery bypass grafting

448

Prognostic significance of heart rate variability in dilated cardiomyopathy

449

Prognostic significance of hepatic encephalopathy in patients with cirrhosis

450

Prognostic significance of HER2, p53, Ki67, MVD-CD34, Cox2, MMP7, and vimentin in gastric cancer

451

Prognostic significance of HER-2/neu overexpression in stage I adenocarcinoma of lung

452

Prognostic Significance of High Sensitivity C-Reactive Protein before and after Percutaneous Coronary Intervention in Patients with Angina Pectoris

453

Prognostic significance of history of stroke among 11507 patients with coronary artery disease

454

Prognostic significance of HOXD4 protein expression in human ovarian cancers

455

Prognostic Significance of Hyponatremia Among Ambulatory Patients With Heart Failure and Preserved and Reduced Ejection Fractions

456

Prognostic significance of immune activation after acute coronary syndromes

457

Prognostic Significance of Impaired Baroreflex Sensitivity Assessed from Phase IV of the Valsalva Maneuver in a Population-Based Sample of Middle-Aged Subjects

458

Prognostic significance of impairment of heart rate response to exercise: Impact of left ventricular function and myocardial ischemia

459

Prognostic Significance of Incident Complete Left Bundle Branch Block Observed Over a 40-Year Period

460

Prognostic Significance of Increased Left Ventricular Mass Index to Mortality and Sudden Death in Patients With Stable Coronary Heart Disease (from the Heart and Soul Study)

461

Prognostic significance of indeterminate lung nodules in renal cell carcinoma

462

Prognostic significance of intracellular survivin in myeloid blast cells as an inhibitor of apoptosis in Egyptian adult acute myeloid leukemia patients

463

Prognostic significance of intra-tumoral estradiol level in breast cancer patients

464

Prognostic significance of intratumoural microvessel density (IMD) in resected pancreatic and ampullary cancers to standard histopathological variables and survival

465

Prognostic significance of Ki-67 and topoisomerase II alpha expression in infiltrating ductal carcinoma of the breast

466

Prognostic significance of Ki-67 and topoisomerase II alpha expression in infiltrating ductal carcinoma of the breast

467

Prognostic significance of late-peaking left ventricular velocity contour in patients with aortic stenosis undergoing valve replacement, ,

468

Prognostic Significance of Left Anterior Hemiblock in Patients With Suspected Coronary Artery Disease Original Research Article

469

Prognostic Significance of Left Atrial Size in Patients With Hypertrophic Cardiomyopathy (from the Italian Registry for Hypertrophic Cardiomyopathy)

470

Prognostic significance of left ventricular diastolic dysfunction in essential hypertension

471

Prognostic Significance of Left Ventricular Diastolic Dysfunction in Patients With Left Ventricular Hypertrophy and Systemic Hypertension (the LIFE Study)

472

Prognostic Significance of LGE by CMR in Aortic Stenosis Patients Undergoing Valve Replacement

473

Prognostic significance of low HDL-C and high triglycerides among diabetic coronary patients

474

Prognostic significance of lymph node metastasis found during pulmonary metastasectomy for extrapulmonary carcinoma

475

Prognostic significance of lymph node reactivity in the control of pathologic negative node squamous cell carcinomas of the oral cavity

476

Prognostic significance of lymphovascular invasion in surgically cured rectal carcinoma

477

Prognostic significance of major histocompatibility complex class II antigens (HLA-DR) in normal colonic mucosa, tubulovillous adenoma, and invasive colonic carcinoma

478

Prognostic Significance of Mammary Tumor Suppressor Gene MASPIN in Breast Cance

479

Prognostic significance of maximal exercise testing after myocardial infarction treated with thrombolytic agents: the GISSI-2 data-base

480

Prognostic Significance of Metastasis to the Highest Mediastinal Lymph Node in Nonsmall Cell Lung Cancer

481

Prognostic Significance of Metastatic Lymph Node Ratio in Patients with Gastric Cancer: an Evaluation in North-East of Iran

482

Prognostic Significance of MGMT Promoter Methylation in Egyptian GBM Patients: A Single-institution Experience

483

Prognostic Significance of MGMT Promoter Methylation in Patients with Glioblastoma Undergoing Surgical Intervention: A Retrospective Study in Northeastern Iran

484

Prognostic significance of microalbuminuria in non-diabetic patients with acute myocardial infarction

485

Prognostic significance of microsatellite instability in curatively resected adenocarcinoma of the small intestine

486

Prognostic significance of microvessel density, vascular cuffing and vascular endothelial growth factor expression in ovarian carcinoma: a special review for clear cell adenocarcinoma

487

Prognostic significance of mild mitral regurgitation by color Doppler echocardiography in acute myocardial infarction

488

Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction

489

Prognostic Significance of MMP2 and MMP9 Functional Promoter Single Nucleotide Polymorphisms in Head and Neck Squamous Cell Carcinoma

490

Prognostic significance of morphological subtypes in canine malignant lymphomas during chemotherapy

491

Prognostic significance of morphometric endomyocardial biopsy analysis in patients with idiopathic dilated cardiomyopathy

492

Prognostic Significance of Myocardial Fibrosis in Hypertrophic Cardiomyopathy

493

Prognostic Significance of Myocardial Fibrosis Quantification by Histopathology and Magnetic Resonance Imaging in Patients With Severe Aortic Valve Disease

494

Prognostic Significance of Myocardial Ischemia by Dobutamine Stress Echocardiography in Patients Without Angina Pectoris After Coronary Revascularization

495

Prognostic Significance of Myocardial Ischemia Detected by Ambulatory Electrocardiography, Exercise Treadmill Testing, and Electrocardiogram at Rest to Predict Cardiac Events by One Year (The Asymptomatic Cardiac Ischemia Pilot [ACIP] Study)

496

Prognostic Significance of Myocardial Ischemia During Dobutamine Stress Echocardiography in Asymptomatic Patients With Diabetes Mellitus and No Prior History of Coronary Events

497

Prognostic significance of neuroendocrine differentiation in adenocarcinoma of the lung

498

Prognostic significance of newly acquired bundle branch block after aortic valve replacement

499

Prognostic significance of nocturnal BP for developing microalbuminuria in IDDM

500

Prognostic significance of nonfatal reinfarction during 3-year follow-up: Results of the thrombolysis in myocardial infarction (TIMI) phase II clinical trial

501

Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma

502

Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma

503

Prognostic Significance of Nonsustained Ventricular Tachycardia During Dobutamine Stress Echocardiography

504

Prognostic significance of normal dobutamine-atropine stress sestamibi scintigraphy in women with chest pain

505

Prognostic Significance of Notch-4, SATB-2, and Glutaminase-1 in Colorectal Adenocarcinoma

506

Prognostic significance of N-Terminal Pro-BNP in patients with COVID-19 pneumonia without previous history of heart failure

507

Prognostic Significance of Nuclear βCatenin Expression in Patients with Colorectal Cancer from Iran

508

Prognostic Significance of Nuclear β-Catenin Expression in Patients with Colorectal Cancer from Iran

509

Prognostic Significance of Oxidative Stress Markers in Colitis Associated with Phenylbutazone Administration in Draft Horses

510

Prognostic significance of oxygen uptake kinetics during low level exercise in patients with heart failure

511

Prognostic significance of p16INK4a/p53 in Tunisian patients with breast carcinoma

512

Prognostic significance of p53 and p63 immunolocalisation in primary and matched lymph node metastasis in oral squamous cell carcinoma

513

Prognostic significance of p53 mutation in suboptimally resected advanced ovarian carcinoma treated with the combination chemotherapy of paclitaxel and carboplatin

514

Prognostic significance of p53 mutations in non-small cell lung cancer: a meta-analysis of 829 cases from eight published studies

515

Prognostic significance of p53, bax and bcl-2 gene expression in patients with laryngeal carcinoma

516

Prognostic significance of P53,Bcl-2,and fas expression in patients with primary gastrointestinal diffuse large B-cell lymphoma

517

Prognostic Significance of PD-L1 and PTEN Expression in Prostatic Cancer

518

Prognostic significance of peri-operative blood transfusion following radical resection for oesophageal carcinoma,

519

Prognostic significance of perioperative serum carcinoembryonic antigen in non-small cell lung cancer: analysis of 1,000 consecutive resections for clinical stage I disease

520

Prognostic significance of peripheral monocytosis after reperfused acute myocardial infarction:a possible role for left ventricular remodeling

521

Prognostic Significance of Periprocedural Versus Spontaneously Occurring Myocardial Infarction After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes: An Analysis From the ACUITY (Acute Catheterization and Urgent Intervention T

522

Prognostic significance of persistent right ventricular dysfunction as assessed by radionuclide angiocardiography in patients with inferior wall acute myocardial infarction

523

Prognostic significance of positive surgical margins after radical prostatectomy among pT2 and pT3a prostate cancer

524

Prognostic significance of positive surgical margins after radical prostatectomy among pT2 and pT3a prostate cancer

525

Prognostic Significance of Postprocedural Sustained Ventricular Tachycardia or Fibrillation in Patients Undergoing Primary Percutaneous Coronary Intervention (from the HORIZONS-AMI Trial)

526

Prognostic significance of precordial ST segment depression during inferior myocardial infarction in the thrombolytic era: Results in 16,521 patients

527

Prognostic significance of precordial ST segment depression on admission electrocardiogram in patients with inferior wall myocardial infarction

528

Prognostic Significance of Preoperative CA72-4 in Patients with Esophageal Squamous Cell Carcinoma

529

Prognostic significance of primary Gleason pattern in Japanese men with Gleason score 7 prostate cancer treated with radical prostatectomy

530

Prognostic significance of primary Gleason pattern in Japanese men with Gleason score 7 prostate cancer treated with radical prostatectomy

531

Prognostic significance of prior preterm twin delivery on subsequent singleton pregnancy

532

Prognostic significance of prostate cancer originating from the transition zone

533

Prognostic Significance of QRS Duration in Patients With Suspected Coronary Artery Disease Referred for Noninvasive Evaluation of Myocardial Ischemia

534

Prognostic Significance of Quantitative QRS Duration

535

Prognostic significance of raised plasma levels of interleukin-6 and C-reactive protein in atrial fibrillation

536

Prognostic significance of reactivation of telomerase in breast core biopsy specimens

537

Prognostic Significance of Reduction in Ki67 Index After Neoadjuvant Chemotherapy in Patients With Breast Cancer in Kerman Between 2009 an‎d 2014

538

Prognostic significance of renal insufficiency in patients presenting with acute coronary syndrome (the Prospective Multicenter SYCOMORE study)

539

Prognostic significance of residual cumulative ST-segment deviation after mechanical reperfusion in patients with ST-segment elevation myocardial infarction

540

Prognostic significance of retrieved lymph nodes per specimenin resected rectal adenocarcinoma after preoperative chemoradiation therapy

541

Prognostic significance of RIN1 gene expression in human non-small cell lung cancer

542

Prognostic significance of selected immunological and biochemical parameters in the cerebrospinal fluid of Ossimi sheep with encephalitic listeriosis

543

Prognostic significance of serum anti-p53 antibody in patients with hepatocellular carcinoma

544

Prognostic significance of serum creatinine concentration for in-hospital mortality in patients with acute myocardial infarction who underwent successful primary percutaneous coronary intervention (from the Heart Institute of Japan Acute Myocardial Infarc

545

Prognostic significance of serum monoclonal immunoglobulin in B-chronic lymphocytic leukemia

546

Prognostic Significance of Serum Total Cholesterol and Triglyceride Levels in Patients Hospitalized for Heart Failure With Reduced Ejection Fraction (from the EVEREST Trial)

547

Prognostic significance of sICAM-1 and sVCAM-1 molecules for cardiac surgery in pediatric patients with pulmonary hypertension

548

Prognostic significance of simvastatin therapy in patients with ischemic heart failure who underwent percutaneous coronary intervention for acute myocardial infarction

549

Prognostic significance of six-minute walk test in non-group 1 pulmonary hypertension

550

Prognostic Significance of Small Troponin I Rise After a Successful Elective Percutaneous Coronary Intervention of a Native Artery

551

Prognostic Significance of Small Troponin I Rise After a Successful Elective Percutaneous Coronary Intervention of a Native Artery

552

Prognostic significance of soluble interleukin-2 receptor-α in adenocarcinoma of the pancreas

553

Prognostic significance of spectral turbulence analysis of the signal-averaged electrocardiogram in patients with idiopathic dilated cardiomyopathy

554

Prognostic Significance of Spontaneous Echo Contrast in the Thoracic Aorta: Relation With Accelerated Clinical Progression of Coronary Artery Disease

555

Prognostic significance of ST segment depression in lateral leads I, aVL, V5 and V6 on the admission electrocardiogram in patients with a first acute myocardial infarction without ST segment elevation

556

Prognostic significance of ST segment monitoring early after myocardial infarction: GUSTO ECG substudy

557

Prognostic Significance of ST Segment Shift Early After Resolution of ST Elevation in Patients With Myocardial Infarction Treated With Thrombolytic Therapy: The GUSTO-I ST Segment Monitoring Substudy

558

Prognostic significance of STAT3 expression and its correlation with chemoresistance of non-small cell lung cancer cells

559

Prognostic significance of stathmin expression in correlation with metastasis and clinicopathological characteristics in human ovarian carcinoma

560

Prognostic significance of ST-segment depression during adenosine perfusion imaging

561

Prognostic significance of ST-segment elevation during dobutamine stress echocardiography

562

Prognostic Significance of Substance P and Neurokinin-1 Receptor in Bladder Cancer

563

Prognostic significance of surgical-pathologic N1 disease in non-small cell carcinoma of the lung

564

Prognostic Significance of Survivin and Nuclear Morphometry in Nasopharyngeal Carcinoma

565

Prognostic Significance of Systolic Blood Pressure Changes During Dobutamine-Atropine Stress Technetium-99m Sestamibi Perfusion Scintigraphy in Patients With Chest Pain and Known or Suspected Coronary Artery Disease

566

Prognostic Significance of Systolic Blood Pressure During Exercise Stress Testing

567

Prognostic Significance of Systolic Blood Pressure Increases in Men During Exercise Stress Testing

568

Prognostic significance of the admission electrocardiogram in acute myocardial infarction

569

Prognostic significance of the coexpression of p53 protein and c-erbB2 in breast cancer

570

Prognostic significance of the dobutamine echocardiography test in idiopathic dilated cardiomyopathy

571

Prognostic significance of the expression levels of the p16, p15, and p14 genes in dogs with high-grade lymphoma

572

Prognostic significance of the location of wall motion abnormalities during exercise echocardiography

573

Prognostic Significance of the Neutrophil-to-Lymphocyte Ratio in Patients with Non-Muscle Invasive Bladder Cancer treated with Intravesical Bacillus Calmette–Guérin and the Relationship with the CUETO Scoring Model

574

Prognostic Significance of the Oxygen Uptake Efficiency Slope: Percent-Predicted Versus Actual Value

575

Prognostic significance of the pouch sign in fetuses with prenatally diagnosed esophageal atresia,

576

Prognostic significance of the size of central fibrosis in peripheral adenocarcinoma of the lung

577

Prognostic Significance of the Tumor Suppressor Gene Maspin in Non–Small Cell Lung Cancer

578

Prognostic Significance of Thrombocytosis in Patients with Locally Advanced Cervical Carcinoma Treated with Chemoradiotherapy

579

Prognostic significance of thymomas in patients with myasthenia gravis

580

Prognostic significance of total number of nodes removed, negative nodes removed, and ratio of positive nodes to removed nodes in node positive breast carcinoma

581

Prognostic significance of TP53 expression for patients with hepatocellular carcinoma: a meta-analysis

582

Prognostic significance of TPA versus SCC-Ag, CEA and neopterin in carcinoma of the uterine cervix

583

Prognostic significance of transient complete atrioventricular block during radiofrequency ablation of atrioventricular node reentrant tachycardia

584

Prognostic significance of transient ischemic episodes: Response to treatment shows improved prognosis Results of the total ischemic burden bisoprolol study (TIBBS) follow-up

585

Prognostic significance of transient no-reflow during primary percutaneous coronary intervention for ST-elevation acute myocardial infarction

586

Prognostic significance of trisomy 6 in an adult acute myeloid leukemia with t(8;21)

587

Prognostic Significance of Troponin Elevation and Right Ventricular Enlargement in Acute Pulmonary Embolism

588

Prognostic Significance of Troponin T Elevation in Patients Without Chest Pain

589

Prognostic significance of troponin T following elective percutaneous coronary intervention: The role of baseline troponin levels

590

Prognostic Significance of TRPS1, GATA3, and CYP4Z1 Expression in Triple-Negative Breast Cancer Patients: An Immunohistochemical Study

591

Prognostic significance of tumor angiogenesis in epithelial ovarian cancer

592

Prognostic significance of tumor angiogenesis in primary fallopian tube cancer

593

Prognostic Significance of Tumor Location in Oncologic Outcome of Colon Cancer

594

Prognostic significance of tumor oxygenation in humans

595

Prognostic significance of two sub-categorization methods for the treatment of binge eating disorder: Negative affect and overvaluation predict, but do not moderate, specific outcomes

596

Prognostic Significance of Valvuloarterial Impedance and Left Ventricular Longitudinal Function in Asymptomatic Severe Aortic Stenosis Involving Three-Cuspid Valves

597

Prognostic significance of vascular endothelial growth factor expression in hepatocellular carcinoma tissue: a meta-analysis

598

Prognostic Significance of VEGF-C Expression in Patients with Breast Cancer: A Meta-Analysis

599

Prognostic stratification of diabetic patients by exercise echocardiography

600

Prognostic Stratification of Patients with Left-Sided Endocarditis Determined at Admission

601

Prognostic stratification of patients with right bundle branch block using dobutamine stress echocardiography

602

Prognostic Stratification of Patients With Vasospastic Angina

603

Prognostic Stratification of Patients With Vasospastic Angina: A Comprehensive Clinical Risk Score Developed by the Japanese Coronary Spasm Association

604

Prognostic studies of canine and feline mammary tumours: The need for standardized procedures

605

Prognostic studies of mammary and other neoplasia in veterinary medicine: A new paradigm

606

Prognostic use of circulating plasma nucleic acid concentrations in patients with acute stroke

607

Prognostic use of echocardiography 1 year after a myocardial infarction

608

Prognostic usefulness of an increase of N-terminal proatrial natriuretic peptide during exercise in patients with chronic heart failure

609

Prognostic Usefulness of Anemia and N-Terminal Pro-Brain Natriuretic Peptide in Outpatients With Systolic Heart Failure

610

Prognostic Usefulness of Circulating High-Sensitivity Troponin T in Aortic Stenosis and Relation to Echocardiographic Indexes of Cardiac Function and Anatomy

611

Prognostic Usefulness of Clinical and Subclinical Peripheral Arterial Disease in Men With Stable Coronary Heart Disease

612

Prognostic Usefulness of C-Reactive Protein: Importance of the Diurnal Variation

613

Prognostic usefulness of dobutamine-induced ST-segment elevation and T-wave normalization after uncomplicated acute myocardial infarction

614

Prognostic Usefulness of Dyspnea Versus Fatigue as Reason for Exercise Test Termination in Patients With Heart Failure

615

Prognostic usefulness of echocardiographic dobutamine in younger (14 to 25 years) and older (40 to 55 years) patients with idiopathic dilated cardiomyopathy

616

Prognostic Usefulness of Free Fatty Acids in Patients With Stable Coronary Heart Disease

617

Prognostic Usefulness of Insulin-Like Growth Factor-Binding Protein 7 in Heart Failure With Reduced Ejection Fraction: A Novel Biomarker of Myocardial Diastolic Function?

618

Prognostic Usefulness of Left Ventricular Hypertrophy by Electrocardiography in Patients With Atrial Fibrillation (from the Randomized Evaluation of Long-Term Anticoagulant Therapy Study)

619

Prognostic usefulness of left ventricular thrombus by echocardiography in dilated cardiomyopathy in predicting stroke, transient ischemic attack, and death

620

Prognostic usefulness of marginal troponin T elevation

621

Prognostic usefulness of plasma monocyte/macrophage and T-lymphocyte activation markers in patients with acute coronary syndromes

622

Prognostic usefulness of repeated echocardiographic evaluation after acute myocardial infarction

623

Prognostic Usefulness of Serial C-Reactive Protein Measurements in ST-Elevation Acute Myocardial Infarction

624

Prognostic Usefulness of Serum Uric Acid After Acute Myocardial Infarction (The Japanese Acute Coronary Syndrome Study)

625

Prognostic Usefulness of the Change in N-terminal pro B-type Natriuretic Peptide Levels to Predict Mortality in a Single Community Cohort Aged ≥70 Years

626

Prognostic usefulness of the six-minute walk in patients with advanced congestive heart failure secondary to ischemic or nonischemic cardiomyopathy

627

Prognostic usefulness of the tricuspid annular plane systolic excursion in patients with congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy

628

Prognostic usefulness of white blood cell count and temperature in acute myocardial infarction (from the CARDINAL Trial)

629

Prognostic Usefulness of White Blood Cell Count on Admission and One-Year Outcome in Patients With Non–ST-Segment Elevation Acute Chest Pain

630

Prognostic utility of a semiquantitative spinal deformity index

631

Prognostic Utility of BCIS Myocardial Jeopardy Score for Classification of Coronary Disease Burden and Completeness of Revascularization

632

Prognostic Utility of B-Type Natriuretic Peptide Assessment in Stable Low-Risk Outpatients With Nonischemic Cardiomyopathy After Decompensated Heart Failure Original Research Article

633

Prognostic utility of CD184 in acute myeloid leukemia

634

Prognostic utility of comparative methods for assessment of ST-segment resolution after primary angioplasty for acute myocardial infarction: The controlled abciximab and device investigation to lower late angioplasty complications (CADILLAC) trial Origin

635

Prognostic Utility of Growth Differentiation Factor-15 in Patients With Chronic Heart Failure Original Research Article

636

Prognostic Utility of Left Ventricular End-Diastolic Pressure in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

637

Prognostic Utility of Metabolic Exercise Testing in Minimally Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy

638

Prognostic Utility of Microvolt T-Wave Alternans in Risk Stratification of Patients With Ischemic Cardiomyopathy Original Research Article

639

Prognostic utility of myocardial blood flow assessed by N-13 ammonia positron emission tomography in patients with idiopathic dilated cardiomyopathy

640

Prognostic utility of myocardial viability assessment

641

Prognostic Utility of Neutrophil Gelatinase-Associated Lipocalin in Predicting Mortality and Cardiovascular Events in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention

642

Prognostic utility of single-photon emission computed tomography in adult patients with hypertrophic cardiomyopathy

643

Prognostic Utility of the Combination of Platelet Count with Neutrophil-to-Lymphocyte Ratio in Aged Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention

644

Prognostic Utility of the SYNTAX Score in Patients With Single Versus Multivessel Disease Undergoing Percutaneous Coronary Intervention (from the Acute Catheterization and Urgent Intervention Triage StrategY [ACUITY] Trial)

645

Prognostic Validity of Red Cell Distribution Width in Neonatal Sepsis

646

Prognostic Value and Echocardiographic Determinants of Plasma Myeloperoxidase Levels in Chronic Heart Failure Original Research Article

647

Prognostic Value of New Electrocardiographic Method for Diagnosis of Left Ventricular Hypertrophy in Essential Hypertension

648

Prognostic value of “high normal” serum creatinine in patients with essential hypertension

649

Prognostic Value of 18F-Fluorocholine PET Parameters in Metastatic Castrate-Resistant Prostate Cancer Patients Treated with Docetaxel

650

Prognostic value of 24-hour ambulatory blood pressure measurement for the onset of atrial fibrillation in treated patients with essential hypertension

651

Prognostic value of 2D echocardiography in patients presenting with acute chest pain and non-diagnostic ECG for ST-elevation myocardial infarction

652

Prognostic Value of 2-Deoxy-2-[18F]fluoro-D-glucose Positron Emission Tomography/Computed Tomography after Autologous Hematopoietic Stem Cell Transplantation in Lymphoma Using Deauville Scores

653

Prognostic Value of 64-Slice Cardiac Computed Tomography: Severity of Coronary Artery Disease, Coronary Atherosclerosis, and Left Ventricular Ejection Fraction

654

Prognostic value of a doppler index combining systolic and diastolic performance in idiopathic-dilated cardiomyopathy

655

Prognostic Value of a High On-Clopidogrel Treatment Platelet Reactivity in Bivalirudin Versus Abciximab Treated Non–ST-Segment Elevation Myocardial Infarction Patients: ISAR-REACT 4 (Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action fo

656

Prognostic Value of a Multimarker Approach for Patients Presenting to Hospital With Acute Chest Pain

657

Prognostic Value of a Multiparametric Risk Score in Patients Undergoing Dipyridamole Stress Echocardiography

658

Prognostic value of a negative stress echocardiographic study in diabetic patients

659

Prognostic Value of a Nine-Minute Treadmill Test in Patients Undergoing Myocardial Perfusion Scintigraphy

660

Prognostic Value of a Restrictive Mitral Filling Pattern in Patients With Systolic Heart Failure and an Implantable Cardioverter-Defibrillator

661

Prognostic value of absolute versus relative measures of the procedural result after successful coronary stenting: Importance of vessel size in predicting long-term freedom from target vessel revascularization

662

Prognostic Value of Adenosine Cardiac Magnetic Resonance Imaging in Patients Presenting With Chest Pain

663

Prognostic Value of Admission Fasting Glucose Levels in Patients With Acute Coronary Syndrome

664

Prognostic value of admission glucose in non-diabetic patients with myocardial infarction

665

Prognostic Value of Admission Hemoglobin Levels in ST-Segment Elevation Myocardial Infarction Patients Presenting With Cardiogenic Shock

666

Prognostic Value of Admission Myeloperoxidase Levels in Patients With ST-Segment Elevation Myocardial Infarction and Cardiogenic Shock

667

Prognostic Value of Admission Neutrophil Count in Asthma Patients with COVID-19: A Comparative Analysis with other Systemic Inflammation Indices for In-Hospital Mortality Prediction

668

Prognostic Value of Admission-to-Discharge Change in Integral Congestion Assessment for Predicting Adverse Outcomes in Patients with Decompensated Heart Failure

669

Prognostic value of ambulatory blood pressure monitoring in refractory hypertension

670

Prognostic Value of Ambulatory Measurement of the Timing of Korotkoff Sounds in Elderly Hypertensives: A Pilot Study

671

Prognostic Value of an Abnormal Ankle–Brachial Index in Patients Receiving Drug-Eluting Stents

672

Prognostic value of an abnormal signal-averaged electrocardiogram in patients with nonischemic dilated cardiomyopathy

673

Prognostic Value of an Exaggerated Exercise Blood Pressure Response in Patients With Diabetes Mellitus and Known or Suspected Coronary Artery Disease

674

Prognostic Value of Anatomical Dominance of Coronary Circulation in Patients with Surgical Myocardial Revascularization

675

Prognostic Value of Androgen Receptor Expression in Bladder Tumors

676

Prognostic Value of Androgen Receptor in Triple Negative Breast Cancer of Iranian Patients in Yazd Region

677

Prognostic value of anemia in predicting sudden death of patients with diastolic heart failure

678

Prognostic Value of Angiographic Lesion Complexity in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention (from the Acute Catheterization and Urgent Intervention Triage Strategy Trial)

679

Prognostic Value of Aortic and Mitral Valve Calcium Detected by Contrast Cardiac Computed Tomography Angiography in Patients With Suspicion of Coronary Artery Disease

680

Prognostic Value of Aortic Valve Area Index in Asymptomatic Patients With Severe Aortic Stenosis

681

Prognostic Value of Aquaporin-3, Vimentin and E-cadherin Expressions in Invasive Breast Carcinoma: An Immunohistochemical Study

682

Prognostic Value of Arterial Blood Gas Indices Regarding the Severity of Traumatic Injury and Fractures of the Femur and Pelvis

683

Prognostic Value of Automatically Detected Early Repolarization

684

Prognostic Value of BAALC Expression in Pediatric Acute Myeloid Leukemia: A Systematic Review

685

Prognostic value of baseline electrophysiology studies in patients with sustained ventricular tachyarrhythmia: The Antiarrhythmics Versus Implantable Defibrillators (AVID) trial

686

Prognostic Value of Blood Pressure Responsiveness in Hemodialysis for Cardiovascular Mortality, Development of A New Predictive Equation

687

Prognostic Value of Brachial Artery Endothelial Function and Wall Thickness Original Research Article

688

Prognostic value of bronchiolo-alveolar carcinoma component of small lung adenocarcinoma

689

Prognostic Value of B-type Natriuretic Peptide for Assessment of Left Ventricular Function in Patients With Chronic Kidney Disease

690

Prognostic Value of B-type Natriuretic Peptide in Patients with Acute Coronary Syndromes

691

Prognostic Value of B-Type Natriuretic Peptides in Patients With Stable Coronary Artery Disease: The PEACE Trial Original Research Article

692

Prognostic value of carbonic anhydrase IX expression in penile squamous cell carcinoma: A pilot study

693

Prognostic value of carbonic anhydrase IX expression in penile squamous cell carcinoma: A pilot study

694

Prognostic value of cardiac autonomic neuropathy independent and incremental to perfusion defects in patients with diabetes and suspected coronary artery disease

695

Prognostic Value of Cardiac Biomarkers and Tissue Doppler Echocardiography to Septic Shock Mortality

696

Prognostic Value of Cardiac Computed Tomography Angiography

697

Prognostic Value of Cardiac Computed Tomography Angiography: A Systematic Review and Meta-Analysis

698

Prognostic Value of Cardiac Troponin I and Left Ventricular Geometry in Pediatric Chronic Hemodialysis: A One Year Follow Up Study

699

Prognostic Value of Cardiac Troponin I Measured With a Highly Sensitive Assay in Patients With Stable Coronary Artery Disease

700

Prognostic Value of Cardiac Troponin T After Noncardiac Surgery: 6-Month Follow-Up Dat

701

Prognostic value of cardiac troponin T in unstable angina pectoris

702

Prognostic value of cardiac troponin-I levels following catheter-based coronary interventions

703

Prognostic value of cardiopulmonary exercise testing using percent achieved of predicted peak oxygen uptake for patients with ischemic and dilated cardiomyopathy

704

Prognostic Value of Cardiopulmonary Exercise Variables in Chronic Heart Failure Patients With or Without Beta-Blocker Therapy

705

Prognostic value of carotid intima-media thickness

706

Prognostic Value of CD44 and HER2/Neu in Invasive Transitional Cell Carcinoma of the Urinary Bladder

707

Prognostic value of CD44 in renal cell carcinoma

708

Prognostic value of cell-cycle regulators and cellular biomarkers in laryngeal squamous cell carcinoma

709

Prognostic Value of Changes in N-Terminal Pro-Brain Natriuretic Peptide in Val-HeFT (Valsartan Heart Failure Trial)

710

Prognostic value of chemokine CCL3 cellular mRNA expression and serum CCL3 level in lymphoma patients

711

Prognostic Value of Chronic Kidney Disease After Transcatheter Aortic Valve Implantation

712

Prognostic value of clinical markers of reperfusion in patients with acute myocardial infarction treated by thrombolytic therapy,

713

Prognostic value of clinical signs and blood parameters in equids suffering from hepatic diseases

714

Prognostic Value of Combined Perfusion and Function by Stress Technetium-99m Sestamibi Gated SPECT Myocardial Perfusion Imaging in Patients With Suspected or Known Coronary Artery Disease

715

Prognostic Value of Computed Tomography Texture Features in Patients with Hepatocellular Carcinoma Following Stereotactic Ablative Radiotherapy

716

Prognostic Value of Concomitant Bronchiectasis in Newly Diagnosed Diffuse Panbronchiolitis Patients on a Maintenance Therapy with Macrolides

717

Prognostic value of congestive heart failure history in patients undergoing percutaneous coronary interventions

718

Prognostic value of copeptin in patients with acute ischemic stroke

719

Prognostic value of coronary artery calcium screening in subjects with and without diabetes Original Research Article

720

Prognostic value of coronary blood flow velocity and myocardial perfusion in intermediate coronary narrowings and multivessel disease

721

Prognostic value of coronary calcification and angiographic stenoses in patients undergoing coronary angiography

722

Prognostic Value of Coronary Computed Tomographic Angiography in Asymptomatic Patients

723

Prognostic value of coronary electron-beam computed tomography for coronary heart disease events in asymptomatic populations

724

Prognostic Value of Coronary Flow Reserve in Medically Treated Patients With Left Anterior Descending Coronary Disease With Stenosis 51% to 75% in Diameter

725

Prognostic Value of Coronary Flow Reserve on Long-Term Cardiovascular Outcomes in Patients With Chronic Kidney Disease

726

Prognostic Value of Coronary Magnetic Resonance Angiography for Prediction of Cardiac Events in Patients With Suspected Coronary Artery Disease

727

Prognostic value of corrected QT-interval prolongation in patients with unstable angina pectoris

728

Prognostic Value of Cortisol in Patients with Acute Ischemic Stroke

729

Prognostic value of C-reactive protein and cardiac troponin I in primary percutaneous interventions for ST-elevation myocardial infarction

730

Prognostic Value of C-Reactive Protein as an Inflammatory and N-Terminal Probrain Natriuretic Peptide as a Neurohumoral Marker in Acute Heart Failure (from the Korean Heart Failure Registry)

731

Prognostic value of C-reactive protein in patients with stress induced myocardial ischemia

732

Prognostic value of C-reactive protein levels within six hours after the onset of acute myocardial infarction

733

Prognostic value of cytokeratin-positive cells in the bone marrow and lymph nodes of patients with resected nonsmall cell lung cancer: a multicenter prospective study

734

Prognostic Value of Depression, Anxiety, and Anger in Hospitalized Cardiovascular Disease Patients for Predicting Adverse Cardiac Outcomes

735

Prognostic Value of Dialysis Effluent Leukocyte Count in Children on Peritoneal Dialysis With Peritonitis

736

Prognostic value of diastolic filling parameters derived using a novel image processing technique in patients ≥70 years of age with congestive heart failure

737

Prognostic Value of Diffusion MR Imaging and Clinical-Pathologic Factors in Patients with Rectal Cancer

738

Prognostic value of dipyridamole imaging in patients with left bundle branch block: review of 96 patients

739

Prognostic Value of Dipyridamole Stress Cardiovascular Magnetic Resonance Imaging in Patients With Known or Suspected Coronary Artery Disease Original Research Article

740

Prognostic value of DNA ploidy response to chemotherapy in human osteosarcomas

741

Prognostic Value of Dobutamine Echocardiography Early After Uncomplicated Acute Myocardial Infarction: Comparison With Exercise Electrocardiography

742

Prognostic value of dobutamine echocardiography in patients after q-wave or non–q-wave acute myocardial infarction

743

Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction

744

Prognostic value of dobutamine stress echocardiography in patients referred because of suspected coronary artery disease

745

Prognostic Value of Dobutamine Stress Echocardiography in Patients Undergoing Diagnostic Coronary Arteriography

746

Prognostic value of dobutamine stress echocardiography in patients with chronic kidney disease

747

Prognostic value of dobutamine stress echocardiography in patients with systemic hypertension and known or suspected coronary artery disease

748

Prognostic value of dobutamine stress echocardiography in predicting cardiac events in patients with known or suspected coronary artery disease

749

Prognostic Value of Dobutamine Stress Echocardiography With Early Injection of Atropine With Versus Without Chronic Beta-Blocker Therapy in Patients With Known or Suspected Coronary Heart Disease

750

Prognostic value of dobutamine stress technetium-99m-sestamibi single-photon emission computed tomography myocardial perfusion imaging: stratification of a high-risk population

751

Prognostic value of dobutamine-atropine sestamibi imaging

752

Prognostic Value of Dobutamine–Atropine Stress Echocardiography Early After Acute Myocardial Infarction

753

Prognostic value of dobutamine-atropine stress technetium-99m sestamibi perfusion scintigraphy in patients with chest pain

754

Prognostic value of Doppler echocardiographic mitral inflow patterns: implications for risk stratification in patients with chronic congestive heart failure

755

Prognostic Value of Doppler Transmitral Flow Velocity Patterns in Acute Myocardial Infarction

756

Prognostic value of doppler ultrasound findings in patients with middle cerebral artery Ischemic stroke

757

Prognostic value of Doppler-derived myocardial performance index in patients with left ventricular systolic dysfunction

758

Prognostic Value of Early Acute Kidney Injury After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction

759

Prognostic Value of Early Exercise Testing After Coronary Stent Implantation

760

Prognostic Value of Early Exercise Testing After Coronary Stent Implantation: A Strategy of Routine Stress Testing After Percutaneous Coronary Intervention Is Not of Proven Benefit

761

Prognostic Value of Early Introduction of Second Line in Patients with Diffuse Large B Cell Lymphoma

762

Prognostic value of E-cadherin expression in thyroid follicular carcinoma

763

Prognostic value of EGF receptor and tumor cell proliferation in bladder cancer: therapeutic implications

764

Prognostic value of electrocardiograms, ventricular late potentials, ventricular arrhythmias, and left ventricular systolic dysfunction in patients with Duchenne muscular dystrophy

765

Prognostic value of electrocardiographic criteria for left ventricular hypertrophy

766

Prognostic Value of Electrocardiographic Measurements Before and After Cardiac Resynchronization Device Implantation in Patients With Heart Failure due to Ischemic or Nonischemic Cardiomyopathy

767

Prognostic value of electroencephalography pattern in prediction of survival and early myoclonus after cardiac arrest

768

Prognostic value of electrophysiologic studies in brugada syndrome

769

Prognostic Value of Elevated Levels of Intestinal Microbe-Generated Metabolite Trimethylamine-N-Oxide in Patients With Heart Failure: Refining the Gut Hypothesis

770

Prognostic Value of Elevated SHIP2 Expression in Laryngeal Squamous Cell Carcinoma

771

Prognostic Value of Elevated White Blood Cell Count in Hypertension

772

Prognostic value of endocardial electromechanical mapping in patients with left ventricular dysfunction undergoing percutaneous coronary intervention

773

Prognostic value of endothelial function

774

Prognostic value of end-tidal carbon dioxide during exercise testing in heart failure

775

Prognostic Value Of End-Tidal Carbon Dioxide Pressures During Out-Of-Hospital Cardiac Arrest, ,

776

Prognostic value of energy metabolism in patients with viral liver cirrhosis

777

Prognostic Value of Epithelial Mesenchymal Transition (EMT Slug) Markers in Ductal Carcinoma of the Breast

778

Prognostic Value of EVI1 Expression in Pediatric Acute Myeloid Leukemia: A Systematic Review

779

Prognostic value of exercise cardiac tomography performed late after percutaneous coronary intervention in symptomatic and symptom-free patients

780

Prognostic value of exercise echocardiography in 2,632 patients ≥65 years of age

781

Prognostic value of exercise echocardiography in patients after coronary artery bypass surgery

782

Prognostic value of exercise echocardiography in patients with classic angina pectoris

783

Prognostic Value of Exercise Echocardiography in Patients With Diabetes Mellitus and Known or Suspected Coronary Artery Disease

784

Prognostic value of exercise echocardiography in women in the community setting

785

Prognostic value of exercise echocardiographyin 5,798 patients: is there a gender difference?

786

Prognostic value of exercise stress myocardial perfusion imaging in patients with permanent pacemakers

787

Prognostic Value of Exercise Stress Technetium-99m-Tetrofosmin Myocardial Perfusion Imaging in Patients With Normal Baseline Electrocardiograms

788

Prognostic value of exercise testing in women after acute coronary syndromes (the Stockholm female coronary risk study)

789

Prognostic value of exercise thallium-201 imaging in a community population, , ,

790

Prognostic Value of Exercise Thallium-201 Imaging Performed Within 2 Years of Coronary Artery Bypass Graft Surgery

791

Prognostic Value of Exercise Tolerance Testing in Asymptomatic Chronic Nonischemic Mitral Regurgitation

792

Prognostic Value of f3-Catenin and S100A4 in Colorectal Carcinoma

793

Prognostic Value of FDG-PET, Based on the Revised Response Criteria, in Patients with Malignant Lymphoma: A Comparison with CT/MRI Evaluations, Based on the International Working Group/ Cotswolds Meeting Criteria

794

Prognostic value of fluorine-18-deoxyglucose (FDG) positron emission tomograpy (PET) in neuroendocrine tumors (NETs)

795

Prognostic value of FOXP3 and TGF-β expression in both peripheral blood and lymph nodes in patients with B-Non Hodgkin’s lymphoma

796

Prognostic Value of Fractional Flow Reserve: Linking Physiologic Severity to Clinical Outcomes

797

Prognostic value of fragmented QRS on a 12-lead ECG in patients with acute myocardial infarction

798

Prognostic Value of Free Plasma Homocysteine Levels in Patients Hospitalized With Acute Coronary Syndrome

799

Prognostic Value of Frontal QRS-T Angle in Patients Without Clinical Evidence of Cardiovascular Disease (from the Multi-Ethnic Study of Atherosclerosis)

800

Prognostic Value of Functional Parameters of 18F-FDG-PET Images in Patients with Primary Renal/Adrenal Lymphoma

801

Prognostic Value of Functional Performance for Mortality in Patients With Peripheral Artery Disease Original Research Article

802

Prognostic value of heart rate adjustment of exercise-induced ST segment depression in the multiple risk factor intervention trial

803

Prognostic value of heart rate recovery in patients with heart failure

804

Prognostic Value of Heart Rate Turbulence and Its Relation to Inflammation in Patients With Unstable Angina Pectoris

805

Prognostic value of heart rate variability during long-term follow-up in patients with mild to moderate heart failure

806

Prognostic value of heart rate variability for sudden death and major arrhythmic events in patients with idiopathic dilated cardiomyopathy

807

Prognostic Value of Heart Rate Variability in Chronic Congestive Heart Failure Secondary to Idiopathic or Ischemic Dilated Cardiomyopathy

808

Prognostic value of heart rate variability in idiopathic dilated cardiomyopathy

809

Prognostic Value of Heart-Type Fatty Acid Binding Protein in Patients with Acute Coronary Syndrome

810

Prognostic value of hemodynamic findings from impedance cardiography in hypertensive stroke

811

Prognostic value of hemoglobin A1c in nondiabetic and diabetic patients with acute ischemic stroke

812

Prognostic Value of Hemoglobin A1C Levels in Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention With Stent Implantation

813

Prognostic value of hemostasis-related parameters for prediction of organ dysfunction and mortality in sepsis

814

Prognostic value of hepatocyte growth factor in dialysis patients with heart failure

815

Prognostic value of hepatocyte growth factor in haemophagocytic lymphohistiocytosis

816

Prognostic value of HER-2/neu and p53 expression in node-positive breast cancer. HER-2/neu effect on adjuvant tamoxifen treatment

817

Prognostic value of HER2/neu expression in patients with prostate cancer: a systematic review

818

Prognostic value of high dose dipyridamole echocardiography in patients with chronic coronary artery disease and preserved left ventricular function

819

Prognostic value of high on-treatment platelet reactivity

820

Prognostic value of high plasma brain natriuretic peptide concentrations in very elderly persons

821

Prognostic Value of High-Dose Dobutamine Stress Magnetic Resonance Imaging in 1,493 Consecutive Patients: Assessment of Myocardial Wall Motion and Perfusion

822

Prognostic Value of Histology in Resected Lung Cancer With Emphasis on the Relevance of the Adenocarcinoma Subtyping

823

Prognostic Value of HLA-G in Malignant Liver and Pancreas Lesions

824

Prognostic value of home heart rate for cardiovascular mortality in the general population: The Ohasama study

825

Prognostic value of HPV DNA in Urothelial Carcinoma of the Bladder: A Preliminary Report of 2-Year Follow-up Results

826

Prognostic value of human erythrocyte acetyl cholinesterase in acute organophosphate poisoning

827

Prognostic value of ictal onset patterns in postsurgical outcome of temporal lobe epilepsy

828

Prognostic Value of Immune Checkpoints in Prostate Cancer: A Systematic Review and Meta-Analysis of Reconstructed Time to Event Data

829

Prognostic value of immunofluorometrically quantifed P53 protein in ovarian carcinoma

830

Prognostic value of immunofluorometrically quantifed P53 protein in ovarian carcinoma

831

Prognostic value of immunohistochemically detected HER-2/neu oncoprotein in endometrial cancer

832

Prognostic Value of IMP3 and Cyclin D1 Expression in Patients with Colorectal Cancer

833

Prognostic Value of Impaired Fasting Glucose for Outcomes of Patients With Stable Angina Pectoris Treated With Percutaneous Coronary Interventions

834

Prognostic Value of Impaired Preoperative Ankle Reflex in Surgical Outcome of Lumbar Disc Herniation

835

Prognostic Value of Impaired Preoperative Ankle Reflex in Surgical Outcome of Lumbar Disc Herniation

836

Prognostic value of infection and inflammation markers for late cardiac events in an Iranian sample

837

Prognostic value of inflammatory biomarkers for predicting the extent of lung involvement and final clinical outcome in patients with COVID‑19

838

Prognostic value of insulin- like growth factor-I receptor expression in renal cell carcinoma

839

Prognostic value of insulin-like growth factor-1 receptors in patients with colon/rectal cancer: Correlation with plasma prolactin

840

Prognostic value of intensive care scores concerning the prediction of 30-day mortality in COVID-19

841

Prognostic value of interleukin-1 receptor antagonist in patients undergoing percutaneous coronary intervention

842

Prognostic Value of Interleukin-6 (IL-6) and Tumor Necrosis Factor-Alpha (TNF-α) in Egyptian Patients with Breast Cancer

843

Prognostic value of interleukin-8 as a predictor of heart failure in patients with myocardial infarction and percutaneous intervention

844

Prognostic Value of Interlukine-1 Receptor Antagonist and Tumor Necrosis Factor Gene Polymorphism in Systemic Inflammatory Response Syndrome

845

Prognostic Value of Intracellular Transcription of Factors HIF-1α and p53 and Their Relation to Estradiol and TNM Parameters of Breast Cancer Tissues in Women with Invasive Ductal Carcinoma in Thi-Qar Province, Iraq

846

Prognostic Value of Intraventricular Dyssynchrony According to Clinical Stage of Left Ventricular Impairment

847

Prognostic Value of Iodine-123-Metaiodobenzylguanidine Myocardial Uptake and Heart Rate Variability in Chronic Congestive Heart Failure Secondary to Ischemic or Idiopathic Dilated Cardiomyopathy

848

Prognostic value of ischemic electrocardiographic findings for cardiovascular mortality in men and women

849

Prognostic value of isolated troponin elevation across the spectrum of chest pain syndromes

850

Prognostic Value of KI6 Biomarker in Predict Short Time Prognosis of Low Grade Cervical Intraepithelial Neoplasia in HPV Negative and Positive Patients

851

Prognostic Value of KI6 Biomarker to Predict Short Term Prognosis of Low Grade Cervical Intraepithelial Neoplasia in Human Papilloma Virus Negative and Positive Patients

852

Prognostic Value of Late Heart Rate Recovery After Treadmill Exercise

853

Prognostic value of left atrial enlargement in patients with idiopathic dilated cardiomyopathy and ischemic cardiomyopathy

854

Prognostic value of left ventricular apical tissue removed for HeartMate II left ventricular assist device placement

855

Prognostic value of left ventricular concentric remodeling in uncomplicated mild hypertension

856

Prognostic value of left ventricular dyssynchrony in patients with heart failure

857

Prognostic value of left ventricular dyssynchrony in patients with heart failure: Reply

858

Prognostic value of left ventricular hypertrophy and geometry in patients with a first, uncomplicated myocardial infarction

859

Prognostic value of left ventricular mass and geometry in systemic hypertension with left ventricular hypertrophy

860

Prognostic value of left ventricular mass and its evolution during treatment in the bordeaux cohort of hypertensive patients

861

Prognostic Value of Left Ventricular Myocardial Performance Index in Patients Undergoing Coronary Artery Bypass Graft Surgery

862

Prognostic Value of Lesion Classification for the Clinical Outcome After Stent Placement

863

Prognostic value of lipoproteins and their relation to inflammatory markers among patients with coronary artery disease

864

Prognostic Value of Location and Type of Myocardial Infarction in the Setting of Advanced Left Ventricular Dysfunction

865

Prognostic Value of Low Blood Glucose at the Presentation of E. coli Bacteremia

866

Prognostic value of low-level cardiac troponin-I elevations in patients without definite acute coronary syndromes

867

Prognostic Value of Lung Sestamibi Uptake in Myocardial Perfusion Imaging of Patients With Known or Suspected Coronary Artery Disease Original Research Article

868

Prognostic Value of Lymph Node Ratio in comparison to Lymph Node Metastases in Stage III Colon Cancer

869

Prognostic value of lymphocytes counts, serum CRP levels, and lung CT scan findings and the final disease outcome in COVID-19

870

Prognostic value of magnetic resonance spectroscopy in patients with diffuse axonal injury: a systematic literature review

871

Prognostic value of mean platelet volume in patients undergoing elective percutaneous coronary intervention

872

Prognostic value of mechanical efficiency in ambulatory patients with idiopathic dilated cardiomyopathy in sinus rhythm

873

Prognostic value of mental stress testing in coronary artery disease

874

Prognostic Value of Midregional Pro-Adrenomedullin in Patients With Acute Myocardial Infarction: The LAMP (Leicester Acute Myocardial Infarction Peptide) Study Original Research Article

875

Prognostic Value of Mid-Regional Pro-Adrenomedullin Levels Taken on Admission and Discharge in Non–ST-Elevation Myocardial Infarction: The LAMP (Leicester Acute Myocardial Infarction Peptide) II Study

876

Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood

877

Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood

878

Prognostic value of minimal residual disease in relapsed childhood acute lymphoblastic leukaemia

879

Prognostic value of mitotic counts in axillary node negative breast cancer patients with predominantly well-differentiated tumours

880

Prognostic Value of Monocyte Count in Patients Hospitalized for Heart Failure With Reduced Ejection Fraction (from the EVEREST Trial)

881

Prognostic Value of Multidetector Coronary Computed Tomographic Angiography for Prediction of All-Cause Mortality Original Research Article

882

Prognostic Value of Multidetector Coronary Computed Tomography Angiography

883

Prognostic Value of Multidetector Coronary Computed Tomography Angiography in Relation to Exercise Electrocardiogram in Patients With Suspected Coronary Artery Disease

884

Prognostic Value of Multiple Biomarkers in American Indians Free of Clinically Overt Cardiovascular Disease (from the Strong Heart Study)

885

Prognostic Value of Multislice Computed Tomography and Gated Single-Photon Emission Computed Tomography in Patients With Suspected Coronary Artery Disease

886

Prognostic Value of Multislice Computed Tomography Coronary Angiography in Patients With Known or Suspected Coronary Artery Disease Original Research Article

887

Prognostic value of mutations and a germ line polymorphism of the p53 gene in non-small cell lung carcinoma: association with clinicopathological features

888

Prognostic value of myeloperoxidase in patients with chest pain

889

Prognostic Value of Myocardial Contrast Delayed Enhancement With 64-Slice Multidetector Computed Tomography After Acute Myocardial Infarction

890

Prognostic Value of Myocardial Contrast Echocardiography in Patients Presenting to Hospital With Acute Chest Pain and Negative Troponin

891

Prognostic Value of Myocardial Infarct Size and Contractile Reserve Using Magnetic Resonance Imaging

892

Prognostic Value of Myocardial Injury Following Transcatheter Aortic Valve Implantation

893

Prognostic Value of Myocardial Ischemic Electrocardiographic Response in Patients With Normal Stress Echocardiographic Study

894

Prognostic value of myocardial perfusion imaging in predicting outcome after renal transplantation

895

Prognostic Value of Myocardial Scar in Atrial Fibrillation

896

Prognostic value of myocardial viability and ischemi detected by dobutamine stress echocardiography early after acute myocardial infarction treated with thrombolysis

897

Prognostic Value of Myocardial Viability by Delayed-Enhanced Magnetic Resonance in Patients With Coronary Artery Disease and Low Ejection Fraction: Impact of Revascularization Therapy

898

Prognostic Value of Myocardial Viability Detected by Myocardial Contrast Echocardiography Early After Acute Myocardial Infarction Original Research Article

899

Prognostic value of myocardial viability recognized by low-dose dobutamine echocardiography in chronic ischemic left ventricular dysfunction

900

Prognostic value of negative dobutamine stress echo in women with intermediate probability of coronary artery disease

901

Prognostic value of negative transesophageal dobutamine stress echocardiography in men at high risk for coronary artery disease

902

Prognostic value of neopterin levels in treated patients with hypertension and chest pain but without obstructive coronary artery disease

903

Prognostic value of neurohormonal activation and cardiopulmonary exercise testing in patients with chronic heart failure

904

Prognostic Value of Neutrophil to Lymphocyte Ratio in Patients Presenting With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

905

Prognostic Value of Neutrophil to Lymphocyte Ratio on Pathologic Findings of Transrectal Ultrasonography Guided Biopsy of Prostate

906

Prognostic value of neutrophil/lymphocyte ratio in patients with pulmonary embolism

907

Prognostic Value of Nocturnal Melatonin Levels as a Novel Marker in Patients With ST-Segment Elevation Myocardial Infarction

908

Prognostic value of nodal micrometastases in patients with cancer of the gastro-oesophageal junction

909

Prognostic value of noninvasive testing one year after orthotopic cardiac transplantation

910

Prognostic Value of Noninvasively Obtained Left Ventricular Contractile Reserve in Patients With Severe Heart Failure

911

Prognostic Value of Normal Adenosine-Stress Cardiac Magnetic Resonance Imaging

912

Prognostic value of normal and non-obstructive coronary artery disease based on CT angiography findings. A 12 month follow up study

913

Prognostic Value of Normal Exercise Echocardiography in a One-Year Follow-up

914

Prognostic value of normal exercise Tc-99m Sestamibi myocardial perfusion imaging in Karachi, Pakistan

915

Prognostic value of normal stress echocardiogram in patients with suspected coronary artery disease—A British general hospital experience

916

Prognostic value of N-terminal pro-atrial and pro-brain natriuretic peptide in patients with acute coronary syndromes

917

Prognostic value of N-terminal proatrial natriuretic factor plasm levels measured within the first 12 hours after myocardial infarction

918

Prognostic Value of N-Terminal Pro-Brain Natriuretic Peptide in Outpatients With Hypertrophic Cardiomyopathy

919

Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Active Infective Endocarditis

920

Prognostic value of N-terminal pro-B-type natriuretic peptide, cytokines and sCD40L in patients with acute heart failure

921

Prognostic Value of N-Terminal Pro–Type-B Natriuretic Peptide and Doppler Left Ventricular Diastolic Variables in Patients With Chronic Systolic Heart Failure Stabilized by Therapy

922

Prognostic value of nucleolar organizer regions in supraglottic carcinoma

923

Prognostic value of osteoprotegerin in heart failure after acute myocardial infarction Original Research Article

924

Prognostic value of overexpression of p53 in human ovarian carcinoma patients receiving cisplatin

925

Prognostic value of p53 and MIB-1 in transitional cell carcinoma of the urinary bladder with regional lymph node involvement: Frank I, Cheville JC, Blute ML, Lohse CM, Karnes RJ, Weaver AL, Sebo TJ, Nehra A, Zincke H, Department of Urology, Mayo Clinic, R

926

Prognostic value of p53 in renal cell carcinoma

927

Prognostic Value of P63, Maspin, and MMP-2 Expression in Salivary Gland Adenoid Cystic Carcinoma

928

Prognostic Value of Pacing-Induced Mechanical Alternans in Patients With Mild-to-Moderate Idiopathic Dilated Cardiomyopathy in Sinus Rhythm Original Research Article

929

Prognostic value of peak exercise systolic blood pressure on long-term survival after myocardial infarction

930

Prognostic value of pentraxin 3 in patients with chronic heart failure

931

PROGNOSTIC VALUE OF P-GLYCOPROTEIN EXPRESSION AND BCL-2/BAX RATIO IN AML PATIENTS

932

Prognostic value of pharmacologic stress echocardiography in patients with left bundle branch block

933

Prognostic Value of Pharmacological Stress Echocardiography in Diabetic and Nondiabetic Patients With Known or Suspected Coronary Artery Disease Original Research Article

934

Prognostic value of pharmacological stress echocardiography in women with chest pain and unknown coronary artery disease

935

Prognostic Value of Plasma Brain Natriuretic Peptide, Urea Nitrogen, and Creatinine in Outpatients >70 Years of Age With Heart Failure

936

Prognostic value of plasma chromogranin A levels in patients with complicated myocardial infarction

937

Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure Original Research Article

938

Prognostic value of plasma fibrinogen concentration in patients with unstable angina and non-Q-wave myocardial infarction (TIMI IIIB Trial)

939

Prognostic Value of Plasma Fibrinolysis Activation Markers in Cardiovascular Disease

940

Prognostic Value of Plasma Ghrelin in Predicting the Outcome of Patients with Chronic Heart Failure

941

Prognostic value of plasma interleukin-6 concentrations and the −174 G > C and −572 G > C promoter polymorphisms of the interleukin-6 gene in patients with acute myocardial infarction treated with thrombolysis

942

Prognostic value of plasma levels of secretory type II phospholipase A2 in patients with unstable angina pectoris

943

Prognostic Value of Plasma Markers of Immune Activation in Patients with Advanced HIV Disease Treated by Combination Antiretroviral Therapy

944

Prognostic Value of Plasma Renin Activity in Heart Failure

945

Prognostic value of plasma soluble intercellular adhesion molecule-1 and endothelin-1 concentration in patients with chronic congestive heart failure

946

Prognostic value of plasma ST2 in patients with non-ST segment elevation acute coronary syndrome

947

Prognostic Value of Platelet Counts in Patients with Metastatic Prostate Cancer Treated with Endocrine Therapy

948

Prognostic Value of Platelet Counts in Patients with Metastatic Prostate Cancer Treated with Endocrine Therapy

949

Prognostic value of platelet indices in patients with acute pulmonary thromboembolism

950

Prognostic value of portal haemodynamics

951

Prognostic value of positive pleural lavage in patients with lung cancer resection

952

Prognostic Value of P-POSSUM and Osteopenia for Predicting Mortality After Emergency Laparotomy in Geriatric Patients

953

Prognostic value of predischarge dipyridamole technetium 99m sestamibi myocardial tomography in medically treated patients with unstable angina

954

Prognostic value of predischarge dobutamine stress echocardiography in chest pain patients with a negative cardiac troponin T

955

Prognostic value of predischarge electrocardiographic measurement of infarct size after thrombolysis: Insights from GUSTO I Economics and Quality of Life substudy

956

Prognostic value of predischarge exercise stress echocardiography after acute myocardial infarction

957

Prognostic value of predischarge exercise testing, ejection fraction, and ventricular ectopic activity in acute myocardial infarction treated with streptokinase

958

Prognostic Value of Preoperative Atrial Fibrillation in Patients With Aortic Stenosis and Low Ejection Fraction Having Aortic Valve Replacement

959

PROGNOSTIC VALUE OF PREOPERATIVE SCIATALGIA IN LUMBAR DISC SURGERY

960

Prognostic value of pretreatment FDG PET/CT in uterine cervical cancer according to two major histologic types: squamous cell carcinoma and adenocarcinoma

961

Prognostic value of pretreatment levels of tumor markers for hepatocellular carcinoma on survival after curative treatment of patients with HCC

962

Prognostic Value of Procalcitonin Recovery Level for Malaria Recrudescence

963

Prognostic value of proliferating cell nuclear antigen in Wilms» tumour in children

964

Prognostic value of prominent DCIS component in the breast-conserving therapy of stage I and II invasive ductal breast cancer

965

Prognostic value of prostate specific antigen before, during and after radiotherapy

966

Prognostic value of pseudonormal and restrictive filling patterns on left ventricular remodelingand cardiac events after coronary artery bypass grafting

967

Prognostic value of pulmonary venous flow Doppler signal in left ventricular dysfunction: contribution of the difference in duration of pulmonary venous and mitral flow at atrial contraction

968

Prognostic Value of Pulse-Wave Tissue Doppler Parameters in Patients With Systolic Heart Failure

969

Prognostic Value of QRS Duration After Transcatheter Aortic Valve Implantation for Aortic Stenosis Using the CoreValve

970

Prognostic value of QT dispersion in acute stroke

971

Prognostic value of QT interval and QT dispersion in patients with left ventricular systolic dysfunction: Results from a cohort of 2265 patients with an ejection fraction of ≤40%

972

Prognostic value of quantitative troponin T measurements in unstable angina/non-ST-segment elevation acute myocardial infarction treated early and predominantly with percutaneous coronary intervention

973

Prognostic value of quantitatively assessed KLK7 expression in ovarian cancer

974

Prognostic value of regional cerebral metabolism in patients undergoing dementia evaluation: comparison to a quantifying parameter of subsequent cognitive performance and to prognostic assessment without PET*1

975

Prognostic value of remnant-like lipoprotein particle levels in patients with coronary artery disease and type ii diabetes mellitus Original Research Article

976

Prognostic Value of Renal Dysfunction for the Prediction of Outcome Versus Results of Computed Tomographic Coronary Angiography

977

Prognostic value of renal function in patients with cardiac resynchronization therapy

978

Prognostic Value of Renal Pathological Findings in Children With Atypical Hemolytic Uremic Syndrome

979

Prognostic value of resting end-tidal carbon dioxide in patients with heart failure

980

Prognostic value of resting thallium-201 imaging: Measurement of infarction but not ischemi predicts outcome

981

Prognostic value of rest-redistribution tomographic thallium-201 imaging in ischemic cardiomyopathy

982

Prognostic Value of Right Heart Catheterization Hemodynamic Dat in Surgically Treated Patients with Coronary Artery Disease

983

Prognostic value of right ventricular myocardial performance index in patients undergoing coronary artery bypass surgery

984

Prognostic Value of Routine Biochemistry Profile of Liver Transplant Patients Admitted to the Emergency Department with a Suspected Infection

985

Prognostic Value of Routine Preoperative Electrocardiography in Patients Undergoing Noncardiac Surgery

986

Prognostic Value of Self-Reported Versus Objectively Measured Functional Capacity in Patients With Heart Failure: Results From the TIME-CHF (Trial of Intensified Versus Standard Medical Therapy in Elderly Patients With Congestive Heart Failure)

987

Prognostic value of serial changes in left ventricular mass in essential hypertension

988

Prognostic Value of Serial Electrocardiographic Voltage and Repolarization Changes in Essential Hypertension: The HEART Survey Study

989

Prognostic Value of Serial Global Longitudinal Strain Measured by Two-Dimensional Speckle Tracking Echocardiography in Patients With ST-Segment Elevation Myocardial Infarction

990

Prognostic Value of Serum Albumin at Admission for Neurologic Outcome with Targeted Temperature Management after Cardiac Arrest

991

Prognostic Value of Serum B-Type Natriuretic Peptide in Early Mortality and Morbidity of Children with Congenital Heart Disease after Open Heart Surgery

992

Prognostic value of serum cardiac troponin I in ambulatory patients with chronic renal failure undergoing long-term hemodialysis: A two-year outcome analysis

993

Prognostic value of serum hyaluronan in patients with compensated HCV cirrhosis

994

Prognostic value of serum interleukin-6 (IL-6) levels in long term care

995

Prognostic value of simultaneous perfusion and function assessment using technetium-99m sestamibi

996

Prognostic Value of Site SYNTAX Score and Rationale for Combining Anatomic and Clinical Factors in Decision Making: Insights From the SYNTAX Trial

997

Prognostic Value of Slow Resolution of ST-Segment Elevation Following Successful Direct Percutaneous Transluminal Coronary Angioplasty for Recovery of Left Ventricular Function

998

Prognostic Value of Soluble ST2 (sST2) Serum Level in Congenital Heart Disease Children with Heart Failure

999

Prognostic value of ST segment depression in acute coronary syndromes: insights from PARAGON-A applied to GUSTO-IIb

1000

Prognostic value of strain and strain rate in the prediction of postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting: a systematic literature review

بازگشت